cirrhosis of liver: A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2738 |
4. Check minimum number of eventsNone |
2738 |
5. Include endpointsNone |
2738 |
6. Filter based on genotype QC (FinnGen only) |
2738 |
Control definitions (FinnGen only)
- Control exclude
- K11_LIVER
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- K70-K77
- Name in latin
- Fibrosis et cirrhosis hepatis
Fibrosis and cirrhosis of liver
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 23725 | 11371 | 11894 |
| Only index persons | 16446 | 8181 | 8265 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.33 | 0.33 | 0.33 |
| Only index persons | 0.31 | 0.30 | 0.32 |
| Median age at first event (years) | |||
| Whole population | 63.88 | 64.27 | 63.53 |
| Only index persons | 63.60 | 63.15 | 64.04 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2738 | 1407 | 1331 |
| Unadjusted period prevalence (%) | 0.53 | 0.48 | 0.59 |
| Median age at first event (years) | 62.66 | 60.36 | 65.09 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2417
- Matched controls
- 24169
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
7.3
323.0
1538
4677
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
536.0
323.0
478
11
A05AA02
ATC
ursodeoxycholic acid; oral
206.5
323.0
704
48
R18
ICD-10 Finland
Ascites
42.7
323.0
462
133
K74.3
ICD-10 Finland
Primary biliary cirrhosis
9896.7
323.0
717
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
61.8
323.0
591
126
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
1887.4
323.0
454
*
C03DA01
ATC
spironolactone; oral
10.7
323.0
934
1348
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
12.5
323.0
802
921
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
+∞
323.0
1526
*
K76.9
ICD-10 Finland
Liver disease, unspecified
428.2
273.2
269
7
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.1
239.3
761
1686
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
6.4
236.9
716
1483
C03CA01
ATC
furosemide; systemic
4.3
233.0
1247
4804
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
59.3
232.7
274
52
K74.0
ICD-10 Finland
Hepatic fibrosis
+∞
207.3
196
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
27.5
193.5
270
110
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
657.4
187.5
183
*
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
1840.8
171.9
165
*
Z94.4
ICD-10 Finland
Liver transplant status
352.6
166.3
166
5
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
50.9
166.2
201
43
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
91.0
159.7
177
21
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
1607.9
153.8
148
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
774.7
149.8
146
*
A06AD11
ATC
lactulose; oral
4.1
144.3
681
2130
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
+∞
140.0
133
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.3
136.3
914
3769
103
Kela drug reimbursment
Diabetes, insulin-treated
3.1
131.4
1001
4492
A10AE04
ATC
insulin glargine; parenteral
4.6
121.6
477
1228
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
12.8
114.3
210
178
K72.9
ICD-10 Finland
Hepatic failure, unspecified
584.8
113.9
112
*
D64.9
ICD-10 Finland
Anaemia, unspecified
4.3
113.1
478
1316
K83.0
ICD-10 Finland
Cholangitis
18.1
109.6
174
103
127
Kela drug reimbursment
Transplant complication
15.2
101.8
173
122
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
4.8
100.7
371
883
K74.5
ICD-10 Finland
Biliary cirrhosis, unspecified
+∞
98.6
94
*
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
497.2
97.1
96
*
D97
ICPC
Liver disease NOS
51.9
94.8
114
23
A07AA11
ATC
rifaximin; oral
+∞
94.4
90
*
UJF32
NOMESCO Finland
Coloscopy
2.7
93.2
874
4243
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.7
92.7
843
4015
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
325.1
92.5
93
*
K92.0
ICD-10 Finland
Haematemesis
9.2
91.9
200
234
K72.1
ICD-10 Finland
Chronic hepatic failure
+∞
89.1
85
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
57.7
88.9
105
19
A10BA02
ATC
metformin; oral
2.5
84.2
910
4716
A07EA06
ATC
budesonide; oral, local oral
7.5
83.8
208
300
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
38.2
83.0
106
29
K70.4
ICD-10 Finland
Alcoholic hepatic failure
836.2
83.0
81
*
K76.7
ICD-10 Finland
Hepatorenal syndrome
+∞
81.7
78
*
B18.2
ICD-10 Finland
Chronic viral hepatitis C
22.5
81.7
120
56
T90
ICPC
Diabetes non-insulin dependent
2.6
81.1
781
3781
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.6
81.1
408
1278
L04AX01
ATC
azathioprine; systemic
5.8
81.0
244
457
C07AA05
ATC
propranolol; systemic
2.8
80.7
613
2577
N02AX02
ATC
tramadol; systemic, rectal
2.3
80.0
1235
7595
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
11.9
79.8
151
135
L04AA06
ATC
mycophenolic acid; systemic
11.4
78.4
151
140
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
19.4
77.8
120
65
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
11.4
77.4
149
138
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
76.6
1253
7856
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.4
75.9
296
736
K92.1
ICD-10 Finland
Melaena
4.9
74.4
261
581
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
4.0
73.9
328
919
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
13.2
73.6
132
105
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.0
72.9
322
898
A10BH01
ATC
sitagliptin; oral
3.4
71.5
391
1299
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
687.1
68.3
67
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
67.1
974
5667
JJ5AT
NOMESCO Finland
NA
341.3
66.8
67
*
K70.1
ICD-10 Finland
Alcoholic hepatitis
655.3
65.2
64
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
17.5
65.2
104
62
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
63.7
655
3207
K75.4
ICD-10 Finland
Autoimmune hepatitis
+∞
62.8
60
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
11.1
62.8
122
115
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
88.8
62.2
69
8
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
613.1
61.0
60
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
60.3
508
2220
L04AD01
ATC
ciclosporin; systemic
8.2
59.5
137
175
UJF30
NOMESCO Finland
Ileoscopy through colon
3.2
59.2
341
1167
A02BC02
ATC
pantoprazole; systemic
2.1
58.7
1676
12641
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
5.6
58.1
178
338
C07AG02
ATC
carvedilol; oral
3.8
58.0
265
754
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
4.2
58.0
239
620
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
7.4
57.7
142
201
TK800
NOMESCO Finland
Hemodialysis
7.1
57.3
145
214
WW500
NOMESCO Finland
Blood transfusion
5.0
54.5
186
399
A10BB12
ATC
glimepiride; oral
3.4
54.3
285
907
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
9.4
54.2
115
128
K70.0
ICD-10 Finland
Alcoholic fatty liver
58.7
53.7
63
11
A10AE05
ATC
insulin detemir; parenteral
4.0
53.5
230
619
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.9
52.7
183
400
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.8
51.7
182
403
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
10.6
51.5
102
100
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.8
50.7
363
1429
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.5
50.6
253
773
JN3AD
NOMESCO Finland
Abdominal CT examination
3.3
50.6
285
954
I50.9
ICD-10 Finland
Heart failure, unspecified
2.5
48.0
428
1909
5716A
ICD-9 Finland
Chronic liver disease and cirrhosis, Biliary cirrhosis[CIRRHOSIS BILIARIS PRIMARIA]
+∞
47.0
45
*
A46
ICD-10 Finland
Erysipelas
2.4
46.3
440
2023
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.5
46.3
229
693
K73.80
ICD-10 Finland
Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)
86.9
46.0
51
6
J01MA02
ATC
ciprofloxacin; systemic
1.9
45.8
1029
6817
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
45.3
473
2282
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
8.1
44.4
102
130
ZX120
NOMESCO Finland
Intravenous
2.8
44.1
315
1232
UJK02
NOMESCO Finland
ERCP
5.7
43.5
130
239
R50.9
ICD-10 Finland
Fever, unspecified
2.4
43.2
411
1885
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.6
43.0
350
1478
K76.6
ICD-10 Finland
Portal hypertension
+∞
42.8
41
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
42.5
335
1387
JJA20
NOMESCO Finland
Open biopsy of liver
38.7
42.0
53
14
A41.9
ICD-10 Finland
Sepsis, unspecified
4.5
41.8
156
366
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.7
41.2
146
325
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.6
41.1
346
1484
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
40.7
350
1519
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.2
40.3
470
2375
E66.00
ICD-10 Finland
Metabolic syndrome
3.5
40.1
200
607
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
12.8
40.0
72
58
H02AB06
ATC
prednisolone; systemic
1.8
39.5
1172
8373
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
39.2
849
5466
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.9
39.0
112
196
WX892
NOMESCO Finland
Monitored bed care
2.9
39.0
259
962
I81
ICD-10 Finland
Portal vein thrombosis
32.5
38.9
51
16
C10AC01
ATC
colestyramine; oral
5.2
38.2
122
243
K29.7
ICD-10 Finland
Gastritis, unspecified
4.2
38.1
153
386
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
38.0
694
4194
K29.6
ICD-10 Finland
Other gastritis
9.8
38.0
78
82
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.2
37.8
214
714
K74.2
ICD-10 Finland
Hepatic fibrosis with hepatic sclerosis
+∞
36.5
35
*
JN4CD
NOMESCO Finland
Very extensive body CT
3.9
36.0
157
426
R94.5
ICD-10 Finland
Abnormal results of liver function studies
10.7
35.9
70
67
SPAT1262
SPAT
Handing over of treatment supplies
2.0
35.7
522
2887
57199
ICD-8 Finland
Cirrhosis of liver, Unspecified
+∞
35.5
34
*
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.4
35.4
180
554
8000/3-C22.0
ICD-O-3
Neoplasm, malignant of liver
96.5
34.8
38
*
160
Kela drug reimbursment
exenatide
5.6
34.7
104
192
N02AA05
ATC
oxycodone; systemic
2.1
33.5
428
2233
XW000
NOMESCO Finland
Bone marrow biopsy
3.5
33.4
165
497
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
6.7
32.7
85
131
R4110
NOMESCO Finland
Physiotherapy
1.8
32.7
689
4338
JJA21
NOMESCO Finland
Laparoscopic biopsy of liver
31.2
32.6
43
14
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.9
32.5
109
229
E87.5
ICD-10 Finland
Hyperkalaemia
6.1
32.4
91
155
I50.0
ICD-10 Finland
Congestive heart failure
2.7
32.1
229
889
205
Kela drug reimbursment
Chronic hypertension
1.8
31.9
761
4977
UJD02
NOMESCO Finland
Gastroscopy
3.2
31.7
176
578
198
Kela drug reimbursment
Sorafenib
24.9
31.4
44
18
Z2446
NOMESCO Finland
Social worker
3.0
31.3
194
687
WX002
NOMESCO Finland
Sedation and analgesia
1.9
31.1
537
3141
K76.89
ICD-10 Finland
Other specified diseases of liver
316.8
30.9
31
*
M04AA01
ATC
allopurinol; systemic
2.1
30.6
372
1895
R06.0
ICD-10 Finland
Dyspnoea
1.8
30.4
626
3891
57198
ICD-8 Finland
Cirrhosis of liver, Alia definita, alcoholismo non indicato
+∞
30.3
29
*
Z2221
NOMESCO Finland
Medical doctor
1.8
30.1
673
4296
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.7
30.0
224
892
I86.4
ICD-10 Finland
Gastric varices
306.1
29.9
30
*
Z51.5
ICD-10 Finland
Palliative care
2.8
29.5
202
763
ZXD05
NOMESCO Finland
Urgent procedure
1.7
29.4
734
4840
JCA32
NOMESCO Finland
Endoscopic injection in oesophagus
50.7
29.4
35
7
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
29.0
454
2557
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.2
28.9
159
519
J01MA12
ATC
levofloxacin; systemic
1.9
28.7
505
2964
177
Kela drug reimbursment
Insulin glargine 300 U / ml
5.3
28.7
89
172
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.2
28.6
157
512
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
28.6
477
2748
K51.5
ICD-10 Finland
Left sided colitis
4.7
28.5
99
217
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
4.3
28.1
108
262
A10BH05
ATC
linagliptin; oral
3.1
28.0
160
536
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
28.0
256
1138
J01FF01
ATC
clindamycin; systemic
1.7
27.9
663
4296
H02AB04
ATC
methylprednisolone; systemic
2.0
27.9
390
2100
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.7
27.9
125
348
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
15.1
27.8
46
31
G93.4
ICD-10 Finland
Encephalopathy, unspecified
25.7
27.5
38
15
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
27.4
563
3480
WX872
NOMESCO Finland
Intensive care
3.0
27.4
164
568
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
3.8
27.4
121
333
57309
ICD-8 Finland
Other diseases of liver, Unspecified
+∞
27.1
26
*
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
62.8
27.0
31
5
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
26.4
420
2372
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.3
26.4
137
429
K29.3
ICD-10 Finland
Chronic superficial gastritis
3.7
26.3
120
339
K74.4
ICD-10 Finland
Secondary biliary cirrhosis
+∞
26.1
25
*
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
+∞
26.1
25
*
ZXE00
NOMESCO Finland
One hour or less
1.6
25.7
912
6582
JN4BD
NOMESCO Finland
Extensive body CT
2.1
25.6
314
1598
C07AB07
ATC
bisoprolol; oral
1.6
25.5
1164
8953
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
28.7
25.4
34
12
Z3226
NOMESCO Finland
Physiotherapist
1.8
25.1
466
2772
K70.2
ICD-10 Finland
Alcoholic fibrosis and sclerosis of liver
+∞
25.0
24
*
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
18.4
24.8
38
21
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.8
24.7
106
285
E66.01
ICD-10 Finland
Obesity due to excess calories
2.6
24.6
196
806
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.3
24.4
127
399
TJA10
NOMESCO Finland
Laparocentesis
18.8
24.3
37
20
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
4.2
24.3
94
230
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
24.2
587
3798
A10BG03
ATC
pioglitazone; oral
3.9
24.0
100
262
Z3231
NOMESCO Finland
Registered nurse
1.7
23.8
669
4514
PC2DE
NOMESCO Finland
Ultrasound examination of liver vasculature with Doppler method
242.3
23.7
24
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.8
23.4
159
598
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
4.4
22.9
84
195
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.9
22.8
142
505
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
4.6
22.8
80
178
N19
ICD-10 Finland
Unspecified kidney failure
3.4
22.7
112
338
R04.0
ICD-10 Finland
Epistaxis
2.4
22.4
206
915
A28
ICPC
Limited function/disability NOS
1.9
22.3
386
2233
A10BJ02
ATC
liraglutide; parenteral
4.0
22.3
90
229
R60.0
ICD-10 Finland
Localized oedema
2.0
22.3
294
1537
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
35.4
22.1
28
8
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.0
21.9
131
453
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
21.9
358
2028
K74.1
ICD-10 Finland
Hepatic sclerosis
+∞
21.9
21
*
UJF92
NOMESCO Finland
Capsular endoscopy
4.7
21.9
75
163
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.9
21.8
140
507
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
3.4
21.7
108
328
L01XE05
ATC
[U] sorafenib; oral
22.4
21.7
31
14
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
4.0
21.6
87
221
JCA20
NOMESCO Finland
Ligature of oesophageal varices
221.9
21.6
22
*
P15
ICPC
Chronic alcohol abuse
4.1
21.6
86
217
N17.8
ICD-10 Finland
Other acute renal failure
7.0
21.5
53
77
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
21.3
321
1764
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.1
21.1
117
385
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
20.8
372
2176
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.9
20.8
131
470
F10.25
ICD-10 Finland
Alcohol dependence continuous use
5.1
20.6
65
129
E66.9
ICD-10 Finland
Obesity, unspecified
3.6
20.6
95
272
A10BX07
ATC
[U] liraglutide; parenteral
5.4
20.6
62
117
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
7.0
20.2
50
73
162
Kela drug reimbursment
liraglutide
6.1
20.1
55
92
A10BD07
ATC
metformin and sitagliptin; systemic
2.7
20.1
142
546
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
20.0
503
3265
A07EC02
ATC
mesalazine; oral, rectal
2.6
19.9
149
593
K83.1
ICD-10 Finland
Obstruction of bile duct
5.4
19.8
60
114
5761C
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]
+∞
19.8
19
*
I85
ICD-10 Finland
Oesophageal varices
+∞
19.8
19
*
K74
ICD-10 Finland
Fibrosis and cirrhosis of liver
+∞
19.8
19
*
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
74.1
19.7
22
*
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
7.4
19.5
46
63
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
8.2
19.4
43
53
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.8
19.4
83
224
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.1
19.1
109
365
A10BX04
ATC
[U] exenatide; parenteral
6.1
19.1
52
87
F10.20
ICD-10 Finland
Alcohol dependence currently independent
4.5
19.0
68
155
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
19.0
671
4753
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
34.6
18.9
24
7
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.3
18.9
95
292
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
18.9
244
1263
I35.0
ICD-10 Finland
Aortic (valve) stenosis
2.4
18.8
166
723
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
28.0
18.7
25
9
S97
ICPC
Chronic ulcer skin
2.5
18.6
150
621
WX882
NOMESCO Finland
High dependency care
3.5
18.6
88
258
AA1AD
NOMESCO Finland
CT of head and brain
1.6
18.4
558
3798
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
2.6
18.3
135
531
E0000UV
ATC
NA
1.5
18.2
846
6371
J01DB01
ATC
cefalexin; oral
1.5
18.2
1847
16384
JN4AD
NOMESCO Finland
Body CT examination
2.1
18.2
211
1042
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
18.2
1380
11512
E66.8
ICD-10 Finland
Other obesity
2.7
18.2
125
475
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
18.1
277
1529
A10BK03
ATC
empagliflozin; oral
2.2
17.9
186
873
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
67.1
17.7
20
*
D73.1
ICD-10 Finland
Hypersplenism
67.1
17.7
20
*
UJK12
NOMESCO Finland
Peroral cholangioscopy
14.7
17.6
29
20
A12BA01
ATC
potassium chloride; oral
2.6
17.5
130
514
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.5
17.4
144
606
E000001
ATC
NA
1.7
17.4
435
2804
R41.0
ICD-10 Finland
Disorientation, unspecified
3.2
17.3
93
301
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.3
17.2
164
742
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
17.2
731
5386
XF600
NOMESCO Finland
Bloodpressure measurement
2.3
17.1
166
756
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
17.1
866
6619
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
17.0
869
6653
N18.8
ICD-10 Finland
Other chronic renal failure
3.1
16.9
94
311
N05CD07
ATC
temazepam; oral
1.8
16.9
322
1912
N05CF01
ATC
zopiclone; oral
1.5
16.9
740
5479
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.4
16.8
145
622
L04AA01
ATC
[U] ciclosporin; systemic
4.3
16.8
63
151
TKC20
NOMESCO Finland
Catheterisation of bladder
2.1
16.8
190
930
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
16.7
589
4149
5719X
ICD-9 Finland
Chronic liver disease and cirrhosis, Unspecified chronic liver disease without mention of alcohol
+∞
16.7
16
*
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
3.0
16.6
95
320
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
7.7
16.6
38
50
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.2
16.6
87
277
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.7
16.5
73
203
V03AE01
ATC
polystyrene sulfonate; oral
5.2
16.5
51
100
A41.8
ICD-10 Finland
Other specified sepsis
4.2
16.5
63
154
A10BB01
ATC
glibenclamide; oral
2.6
16.5
124
494
RS120
NOMESCO Finland
NA
23.2
16.4
23
10
RS220
NOMESCO Finland
NA
5.2
16.2
50
98
M10.9
ICD-10 Finland
Gout, unspecified
2.2
16.2
168
792
R02
ICPC
Shortness of breath/dyspnoea
1.8
16.1
284
1645
R53
ICD-10 Finland
Malaise and fatigue
1.6
16.0
450
2992
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.2
15.9
85
274
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
3.3
15.9
80
247
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
6.1
15.9
43
72
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
15.8
290
1702
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
15.8
671
4924
6611
FHL
Needle biopsy in the operating room
60.4
15.8
18
*
R60.9
ICD-10 Finland
Oedema, unspecified
2.5
15.7
126
520
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
15.7
344
2132
E87.6
ICD-10 Finland
Hypokalaemia
3.1
15.7
87
288
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
15.7
337
2078
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.6
15.6
119
478
5715A
ICD-9 Finland
Chronic liver disease and cirrhosis, Cirrhosis of liver without mention of alcohol
+∞
15.6
15
*
E88.0
ICD-10 Finland
Disorders of plasma-protein metabolism, not elsewhere classified
22.2
15.5
22
10
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.9
15.5
96
342
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.3
15.5
140
619
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
3.0
15.4
91
315
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.8
15.4
101
374
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
7.7
15.4
35
46
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.7
15.3
103
386
XCK10
NOMESCO Finland
Photography of fundus of eye
1.9
15.3
253
1434
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.6
15.2
68
192
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.3
15.2
56
133
I50
ICD-10 Finland
Heart failure
2.9
15.1
93
330
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
15.1
309
1873
A10AB06
ATC
insulin glulisine; parenteral
5.5
15.1
44
81
L28
ICPC
Limited function/disability (L)
1.7
15.1
373
2392
A08
ICPC
Swelling
2.6
15.0
113
454
K42.0
ICD-10 Finland
Umbilical hernia with obstruction, without gangrene
5.6
14.9
43
78
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
31.9
14.8
19
6
WVA20
NOMESCO Finland
Medicine administration
3.6
14.8
67
191
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
4.0
14.8
59
151
ZX108
NOMESCO Finland
Inhalation
7.2
14.8
35
49
L04AA05
ATC
[U] tacrolimus; systemic
21.2
14.6
21
10
D07AC01
ATC
betamethasone; topical
1.5
14.6
741
5620
K76.1
ICD-10 Finland
Chronic passive congestion of liver
+∞
14.6
14
*
5714X
ICD-9 Finland
Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ALIA SEU NUD]
+∞
14.6
14
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.2
14.5
77
248
N05BA04
ATC
oxazepam; oral
1.5
14.4
527
3725
JAH00
NOMESCO Finland
Laparotomy
3.0
14.4
82
276
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.5
14.4
112
458
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.2
14.3
54
131
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
11.4
14.3
26
23
3A422
NOMESCO Finland
NA
42.7
14.1
17
*
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.8
14.0
244
1405
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
7.3
14.0
33
46
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.1
13.9
158
774
M34.1
ICD-10 Finland
CR(E)ST syndrome
7.8
13.8
31
40
B01AA03
ATC
warfarin; systemic
1.5
13.7
459
3175
D64.8
ICD-10 Finland
Other specified anaemias
4.0
13.7
54
137
JAH01
NOMESCO Finland
Laparoscopy
2.5
13.7
107
437
K50.8
ICD-10 Finland
Other Crohn disease
4.2
13.7
51
123
K80.3
ICD-10 Finland
Calculus of bile duct with cholangitis
6.4
13.7
35
55
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
5.3
13.6
41
79
JJC60
NOMESCO Finland
Total excision of transplanted liver
+∞
13.6
13
*
A10BJ06
ATC
semaglutide; parenteral
2.8
13.5
88
324
C09AA02
ATC
enalapril; systemic
1.5
13.5
466
3246
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
11.0
13.5
25
23
SPAT1255
SPAT
Intravenous administration of medicine
2.0
13.4
164
831
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
6.0
13.3
36
61
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
13.3
517
3696
F10.24
ICD-10 Finland
Alcohol depence active use
4.3
13.2
48
113
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.2
13.2
135
634
3AC01
NOMESCO Finland
NA
4.8
13.1
43
91
323
Kela drug reimbursment
Sorafenib
40.3
13.1
16
*
M05BA04
ATC
alendronic acid; oral
1.9
13.1
205
1140
B80
ICPC
Iron deficiency anaemia
3.7
13.0
56
154
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
3.9
13.0
53
139
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
3.4
13.0
63
191
K65.0
ICD-10 Finland
Acute peritonitis
4.7
12.9
43
93
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.8
12.9
84
310
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
12.8
446
3105
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.8
12.8
226
1306
C01AA05
ATC
digoxin; systemic
1.9
12.8
195
1074
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
4.6
12.7
43
95
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
15.5
12.6
20
13
S42.2
ICD-10 Finland
Fracture of upper end of humerus
2.4
12.6
110
480
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
3.6
12.5
56
159
R4190
NOMESCO Finland
Nutritional therapy
2.7
12.5
87
335
K75.3
ICD-10 Finland
Granulomatous hepatitis, not elsewhere classified
+∞
12.5
12
*
A02BC01
ATC
omeprazole; systemic
1.4
12.5
611
4577
B01AB05
ATC
enoxaparin; parenteral
1.4
12.4
678
5190
A10BK01
ATC
dapagliflozin; oral
2.3
12.3
111
491
SPAT1265
SPAT
Breathalyser
6.0
12.2
33
56
B82
ICPC
Anaemia other/unspecified
2.9
12.2
72
251
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.0
12.2
71
245
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
5.0
12.2
38
77
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.0
12.1
154
790
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
3.8
12.1
51
138
K26.9
ICD-10 Finland
Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation
5.1
12.1
37
73
A10BJ05
ATC
dulaglutide; parenteral
6.1
12.1
32
53
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
6.1
12.1
32
53
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
5.4
12.1
35
65
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
12.0
785
6194
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
11.1
12.0
22
20
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
46.9
11.9
14
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.3
11.8
107
473
T89
ICPC
Diabetes insulin dependent
2.6
11.8
86
340
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
11.8
11.8
21
18
E66.0
ICD-10 Finland
Obesity due to excess calories
4.6
11.7
40
89
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
11.7
157
823
K51.8
ICD-10 Finland
Other ulcerative colitis
4.3
11.6
42
99
N06AX11
ATC
mirtazapine; oral
1.4
11.6
657
5045
J94.8
ICD-10 Finland
Other specified pleural conditions
3.5
11.6
53
154
3A064
NOMESCO Finland
NA
11.1
11.5
21
19
C08CA01
ATC
amlodipine; oral
1.4
11.5
818
6539
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
11.5
115
534
K76.4
ICD-10 Finland
Peliosis hepatis
+∞
11.5
11
*
K71.9
ICD-10 Finland
Toxic liver disease, unspecified
+∞
11.5
11
*
K73.89
ICD-10 Finland
Other long-term hepatitis, not classified differently
+∞
11.5
11
*
K75.8
ICD-10 Finland
Other specified inflammatory liver diseases
+∞
11.5
11
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
11.4
372
2546
JJA44
NOMESCO Finland
Laparoscopic destruction of lesion of liver
120.6
11.4
12
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.7
11.4
244
1499
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
15.1
11.3
18
12
N30.0
ICD-10 Finland
Acute cystitis
1.6
11.3
287
1847
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
35.2
11.3
14
*
JDA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in stomach or pylorus
10.6
11.3
21
20
D69.5
ICD-10 Finland
Secondary thrombocytopenia
10.6
11.3
21
20
JDA32
NOMESCO Finland
Endoscopic injection in stomach or pylorus
9.6
11.2
22
23
UJF02
NOMESCO Finland
Peroral enteroscopy
6.2
11.2
29
47
K29.0
ICD-10 Finland
Acute haemorrhagic gastritis
5.7
11.2
31
55
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
3.9
11.2
44
113
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.1
11.1
127
628
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.2
11.0
110
511
201
Kela drug reimbursment
Chronic cardiac insufficiency
2.1
11.0
119
570
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
11.0
237
1458
N05BA01
ATC
diazepam; systemic, rectal
1.6
11.0
287
1860
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.2
11.0
109
503
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
3.0
11.0
63
215
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.1
11.0
60
200
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
6.9
10.8
26
38
A10BH02
ATC
vildagliptin; oral
3.0
10.8
62
211
C09AA05
ATC
ramipril; oral
1.4
10.8
558
4206
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.9
10.8
164
903
K86.1
ICD-10 Finland
Other chronic pancreatitis
4.9
10.8
34
70
K65.9
ICD-10 Finland
Peritonitis, unspecified
10.6
10.8
20
19
JDA42
NOMESCO Finland
Other endoscopic haemostatic procedure in stomach or pylorus
8.9
10.8
22
25
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
4.2
10.7
39
93
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
10.7
187
2934
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.7
10.7
35
75
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.7
10.7
72
273
N06AX16
ATC
venlafaxine; oral
1.6
10.7
255
1615
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.9
10.7
151
810
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
3.3
10.7
53
165
E83.1
ICD-10 Finland
Disorders of iron metabolism
6.7
10.7
26
39
K55.2
ICD-10 Finland
Angiodysplasia of colon
6.7
10.7
26
39
K07
ICPC
Swollen ankles/oedema
2.2
10.6
107
499
SPAT1254
SPAT
Administration of medicine
1.6
10.6
320
2150
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
10.6
260
1657
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
6.0
10.6
28
47
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
6.0
10.6
28
47
R60.1
ICD-10 Finland
Generalized oedema
7.0
10.6
25
36
TGC00
NOMESCO Finland
Bronchial lavation
2.7
10.5
71
270
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
10.5
159
875
TK810
NOMESCO Finland
Hemofiltration
6.2
10.4
27
44
H02AB09
ATC
hydrocortisone; systemic
3.1
10.4
55
179
K75.0
ICD-10 Finland
Abscess of liver
+∞
10.4
10
*
I98.2
ICD-10 Finland
Oesophageal varices without bleeding in diseases classified elsewhere
+∞
10.4
10
*
5714B
ICD-9 Finland
Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ACTIVA (HBSAG-)]
+∞
10.4
10
*
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
10.4
228
1408
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
2.9
10.4
61
213
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
12.1
10.3
18
15
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
32.7
10.3
13
*
C02EA02
ATC
NA
2.1
10.3
114
554
Z72.1
ICD-10 Finland
Alcohol use
4.4
10.3
36
83
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
4.3
10.3
37
88
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
18.9
10.3
15
8
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
4.8
10.2
33
70
D25
ICPC
Abdominal distension
3.3
10.2
50
154
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
23.5
10.2
14
6
N07BB01
ATC
disulfiram; oral
2.3
10.2
94
421
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
10.2
368
2576
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.7
10.2
226
1398
B03XA02
ATC
darbepoetin alfa; parenteral
3.1
10.2
55
182
K50.9
ICD-10 Finland
Crohn disease, unspecified
3.6
10.2
44
123
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
7.5
10.2
23
31
A40.8
ICD-10 Finland
Other streptococcal sepsis
4.7
10.1
33
71
Z94.0
ICD-10 Finland
Kidney transplant status
3.9
10.1
40
104
H3600, E113
ICD-10 Finland
NA
3.7
10.1
42
114
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
10.1
134
702
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.8
10.0
181
1056
JAF10
NOMESCO Finland
Repair of umbilical hernia
2.8
10.0
61
219
RD210
NOMESCO Finland
NA
3.2
10.0
50
157
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.1
10.0
112
549
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.7
10.0
206
1252
L04AA10
ATC
sirolimus; oral
40.2
10.0
12
*
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.1
10.0
53
174
E000006
ATC
NA
1.9
9.9
149
816
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
16.8
9.9
15
9
G62.1
ICD-10 Finland
Alcoholic polyneuropathy
12.2
9.8
17
14
D50.8
ICD-10 Finland
Other iron deficiency anaemias
3.6
9.8
43
122
5739X
ICD-9 Finland
Other disorders of liver, Unspecified disorder of liver
20.1
9.8
14
7
D05AX52
ATC
calcipotriol, combinations; topical
2.0
9.8
126
653
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
7.0
9.8
23
33
K05.31
ICD-10 Finland
Periodontitis pronounced
1.7
9.8
217
1344
R03AC02
ATC
salbutamol; inhalant
1.3
9.8
1079
9171
WX402
NOMESCO Finland
General anaesthesia
1.5
9.7
340
2360
WX419
NOMESCO Finland
Other general anesthesy
4.0
9.7
37
93
A07AA09
ATC
vancomycin; oral
3.9
9.7
38
98
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
3.8
9.7
39
103
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.7
9.7
63
236
N06AB04
ATC
citalopram; systemic
1.4
9.7
432
3159
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
4.2
9.7
35
84
EBA10
NOMESCO Finland
Surgical removal of tooth
1.7
9.6
189
1129
K02.2
ICD-10 Finland
Caries of cementum
2.1
9.6
105
510
N05AH04
ATC
quetiapine; oral
1.5
9.6
297
2006
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
3.1
9.6
51
168
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
9.4
656
5192
K75.2
ICD-10 Finland
Nonspecific reactive hepatitis
100.4
9.4
10
*
2BB01
NOMESCO Finland
NA
100.4
9.4
10
*
5718X
ICD-9 Finland
Chronic liver disease and cirrhosis, Other chronic nonalcoholic liver disease
+∞
9.4
9
*
57300
ICD-8 Finland
Other diseases of liver, Hepatitis NUD
+∞
9.4
9
*
C22
ICD-10 Finland
Malignant neoplasm of liver and intrahepatic bile ducts
+∞
9.4
9
*
K73.8
ICD-10 Finland
Other chronic hepatitis, not elsewhere classified
+∞
9.4
9
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
9.4
168
977
K65.8
ICD-10 Finland
Other peritonitis
12.4
9.4
16
13
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.5
9.3
68
272
F10.09
ICD-10 Finland
Alcohol intoxication UNS
3.1
9.3
50
166
R11
ICD-10 Finland
Nausea and vomiting
1.8
9.3
162
934
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
4.3
9.3
33
78
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.7
9.3
60
224
Z72.2
ICD-10 Finland
Drug use
9.5
9.3
18
19
K08.3
ICD-10 Finland
Retained dental root
1.8
9.2
149
838
K50.1
ICD-10 Finland
Crohn disease of large intestine
4.1
9.2
34
83
A11CC03
ATC
alfacalcidol; systemic
2.6
9.2
66
259
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
6.0
9.2
24
40
JKA20
NOMESCO Finland
Cholecystectomy
2.5
9.2
70
286
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
9.2
137
749
G03FA14
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.3
9.1
23
690
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
3.1
9.1
47
152
F05.9
ICD-10 Finland
Delirium, unspecified
3.0
9.1
52
178
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
6.3
9.1
23
37
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
2.4
9.0
76
328
A10BX02
ATC
repaglinide; oral
3.5
9.0
40
115
H02AB07
ATC
prednisone; oral
1.5
9.0
311
2154
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
9.0
197
1217
K26.0
ICD-10 Finland
Duodenal ulcer, acute with haemorrhage
4.9
9.0
28
58
K80.8
ICD-10 Finland
Other cholelithiasis
3.1
9.0
46
148
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
9.0
203
1267
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.4
9.0
41
121
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.4
8.9
72
304
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
8.9
363
2602
N03AX16
ATC
pregabalin; oral
1.4
8.9
499
3805
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
12.6
8.9
15
12
C03AA03
ATC
hydrochlorothiazide; oral
1.6
8.8
214
1360
C07AB02
ATC
metoprolol; systemic
1.4
8.8
454
3406
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
4.3
8.8
31
73
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
10.7
8.8
16
15
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.6
8.8
60
231
E87.2
ICD-10 Finland
Acidosis
6.3
8.8
22
35
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
5.6
8.7
24
43
K55.8
ICD-10 Finland
Other vascular disorders of intestine
5.6
8.7
24
43
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
3.6
8.7
37
103
M01AB01
ATC
indometacin; systemic, rectal
1.7
8.7
184
1124
A10BD03
ATC
metformin and rosiglitazone; systemic
3.0
8.7
47
157
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
2.6
8.7
60
233
E86
ICD-10 Finland
Volume depletion
2.6
8.7
60
233
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
14.1
8.7
14
10
A02BD07
ATC
lansoprazole, amoxicillin and clarithromycin; systemic
2.0
8.7
109
561
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.7
8.7
172
1033
D07AD01
ATC
clobetasol; topical
1.5
8.6
316
2216
P01AB01
ATC
metronidazole; oral, rectal
1.3
8.6
804
6633
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
5.0
8.6
26
52
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
8.6
379
2758
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
16.3
8.5
13
8
JAF30
NOMESCO Finland
Repair of umbilical hernia using prosthetic material
2.8
8.5
54
198
XF612
NOMESCO Finland
Measurement of central venous pressure
9.0
8.5
17
19
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
10.1
8.5
16
16
K02.9
ICD-10 Finland
Dental caries, unspecified
3.3
8.5
40
121
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.5
8.5
343
2452
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.2
8.5
82
376
B17.1
ICD-10 Finland
Acute hepatitis C
20.1
8.5
12
6
R03BB04
ATC
tiotropium bromide; inhalant
1.6
8.4
224
1456
A98
ICPC
Health maint/preventive medicine
0.7
8.4
1996
21027
SPAT1088
SPAT
Blood transfusion
5.7
8.4
23
41
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
3.8
8.4
34
91
K70
ICD-10 Finland
Alcoholic liver disease
90.4
8.4
9
*
B01AB10
ATC
tinzaparin; parenteral
1.8
8.4
147
848
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
8.4
324
2294
ZZA00
NOMESCO Finland
Split skin graft
2.3
8.4
74
327
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.0
8.4
45
150
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.4
8.4
38
112
D02AE01
ATC
carbamide; topical
1.8
8.4
136
768
RS122
NOMESCO Finland
NA
12.8
8.4
14
11
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
6.7
8.4
20
30
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
8.4
464
3524
A07AA02
ATC
nystatin; oral
1.8
8.3
145
838
JCA35
NOMESCO Finland
Endoscopic contact coagulation in oesophagus
+∞
8.3
8
*
R16.2
ICD-10 Finland
Hepatomegaly with splenomegaly, not elsewhere classified
+∞
8.3
8
*
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.3
8.3
76
342
M10.0
ICD-10 Finland
Idiopathic gout
2.3
8.3
74
330
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.4
8.3
68
291
Z94.1
ICD-10 Finland
Heart transplant status
10.8
8.3
15
14
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
9.5
8.3
16
17
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.7
8.2
175
1074
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
8.2
465
3543
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.7
8.2
53
198
A10BJ01
ATC
exenatide; parenteral
4.2
8.2
29
69
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.7
8.2
54
206
J01DA01
ATC
[U] cefalexin; systemic
1.3
8.1
1329
11795
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.1
8.1
87
419
S18
ICPC
Laceration/cut
1.3
8.1
905
7637
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.0
8.1
44
148
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.1
8.1
89
432
D23
ICPC
Hepatomegaly
33.5
8.1
10
*
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
17.2
8.1
12
7
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
11.7
8.1
14
12
A40.1
ICD-10 Finland
Sepsis due to streptococcus, group B
11.7
8.1
14
12
S76
ICPC
Skin infection other
1.9
8.1
108
568
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.8
8.0
133
754
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.1
8.0
93
462
A10AE06
ATC
insulin degludec; parenteral
2.5
8.0
62
255
C08CA02
ATC
felodipine; oral
1.6
8.0
206
1329
K81.9
ICD-10 Finland
Cholecystitis, unspecified
3.8
8.0
32
85
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.8
8.0
48
172
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.6
8.0
212
1379
UJD10
SPAT
NA
3.4
8.0
37
111
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
3.1
8.0
41
133
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.8
8.0
127
713
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
3.1
8.0
42
139
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.8
7.9
134
768
A10BB07
ATC
glipizide; oral
3.1
7.9
41
134
EBA00
NOMESCO Finland
Extraction of tooth
1.3
7.9
638
5143
JDA22
NOMESCO Finland
Endoscopic ligature of varices of stomach
13.1
7.9
13
10
Z71.4
ICD-10 Finland
Alcohol abuse counselling and surveillance
7.8
7.9
17
22
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
7.9
1014
8714
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
7.8
610
4890
SPAT1263
SPAT
Sampling
1.3
7.8
869
7320
A04
ICPC
Weakness/tiredness general
1.5
7.8
241
1625
Z3229
NOMESCO Finland
Other healthcare associate professional
1.6
7.8
188
1191
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
7.8
351
2563
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.3
7.8
67
294
A63.0
ICD-10 Finland
Anogenital (venereal) warts
2.7
7.8
50
187
K86.2
ICD-10 Finland
Cyst of pancreas
4.0
7.8
29
73
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.8
7.7
127
722
R77.0
ICD-10 Finland
Abnormality of albumin
15.1
7.7
12
8
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
7.7
338
2457
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
4.6
7.7
25
55
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
5.6
7.7
21
38
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.8
7.6
30
79
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.4
7.6
375
2786
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
7.6
154
933
L29.9
ICD-10 Finland
Pruritus, unspecified
2.5
7.6
57
233
A10BX01
ATC
guar gum; systemic
2.1
7.6
84
413
K76.80
ICD-10 Finland
Hepatic cyst
18.4
7.6
11
6
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
2.9
7.6
42
144
3049X
ICD-9 Finland
Drug dependence, Unspecified drug dependence
25.1
7.6
10
*
474
NOMESCO Finland
NA
25.1
7.6
10
*
WX110
NOMESCO Finland
Local anesthesy
1.3
7.6
1409
12660
Z02.7
ICD-10 Finland
Issue of medical certificate
1.8
7.5
125
712
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
5.8
7.5
20
35
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
7.5
503
3940
H3601, E113
ICD-10 Finland
NA
2.9
7.5
43
149
A10BG02
ATC
rosiglitazone; oral
3.0
7.5
41
140
A02BC03
ATC
lansoprazole; oral
1.3
7.5
613
4947
JL5AM
NOMESCO Finland
Bile and pancreas ducts simple MRI examination with 3 Tesla magnet
80.3
7.4
8
*
4560A
ICD-9 Finland
Varicose veins of other sites, Oesophageal varices with bleeding
80.3
7.4
8
*
H26.3
ICD-10 Finland
Drug-induced cataract
5.0
7.4
22
44
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.8
7.4
45
164
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.9
7.4
107
583
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
13.4
7.4
12
9
176
Kela drug reimbursment
Regorafenib
13.4
7.4
12
9
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
2.0
7.4
93
482
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
3.6
7.4
31
87
K25.3
ICD-10 Finland
Gastric ulcer, Acute without haemorrhage or perforation
3.9
7.4
28
72
S29
ICPC
Skin symptom/complaint other
1.4
7.3
336
2461
B03BA03
ATC
hydroxocobalamin; parenteral
1.8
7.3
127
733
XG410
NOMESCO Finland
Flow-volume spirometry
2.0
7.3
90
460
E000003
ATC
NA
2.0
7.3
90
460
L01BB02
ATC
mercaptopurine; oral
4.3
7.3
25
58
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
8.4
7.3
15
18
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.6
7.3
169
1063
57308
ICD-8 Finland
Other diseases of liver, Alii definiti
+∞
7.3
7
*
K71.2
ICD-10 Finland
Toxic liver disease with acute hepatitis
+∞
7.3
7
*
6615
FHL
Liver transplant
+∞
7.3
7
*
K76.5
ICD-10 Finland
Hepatic veno-occlusive disease
+∞
7.3
7
*
ZXE90
NOMESCO Finland
More than 22 hours
4.2
7.3
26
63
A02BC05
ATC
esomeprazole; systemic
1.3
7.3
848
7175
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
9.4
7.3
14
15
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
9.4
7.3
14
15
K22.6
ICD-10 Finland
Gastro-oesophageal laceration-haemorrhage syndrome
4.9
7.3
22
45
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.9
7.3
100
535
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
3.2
7.2
36
115
I50.1
ICD-10 Finland
Left ventricular failure
1.9
7.2
102
551
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
7.2
282
2000
602
Kela drug reimbursment
Children's severe malnutrition
15.8
7.2
11
7
A09AA02
ATC
multienzymes (lipase, protease etc.)
2.6
7.2
48
185
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.8
7.2
122
699
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.4
7.2
32
94
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.6
7.2
203
1341
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
3.3
7.2
34
105
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.1
7.2
36
116
F60.9
ICD-10 Finland
Personality disorder, unspecified
3.9
7.2
27
69
XPX08
NOMESCO Finland
Intraoperative flow measurement
3.7
7.2
29
79
RS321
NOMESCO Finland
NA
20.1
7.1
10
5
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.2
7.1
71
335
N40
ICD-10 Finland
Hyperplasia of prostate
0.7
7.1
253
3462
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
12.1
7.1
12
10
J01AA02
ATC
doxycycline; systemic
1.3
7.1
1722
15922
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
3.6
7.1
30
85
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
6.0
7.1
18
30
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
6.0
7.1
18
30
K85
ICD-10 Finland
Acute pancreatitis
2.6
7.1
47
181
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.9
7.1
106
584
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
4.7
7.0
22
47
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.9
7.0
94
499
XF622
NOMESCO Finland
Measurement of minute volume of heart
7.0
7.0
16
23
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
3.0
7.0
37
124
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
7.0
244
1695
A03
ICPC
Fever
1.5
6.9
255
1787
2BD01
NOMESCO Finland
NA
7.5
6.9
15
20
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
13.8
6.9
11
8
D07AC13
ATC
mometasone; topical
1.3
6.9
580
4690
L76
ICPC
Fracture: other
2.3
6.9
61
273
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
2.1
6.8
73
353
DKW30
NOMESCO Finland
Cauterisation of artery of internal nose
4.8
6.8
21
44
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
6.7
6.8
16
24
S91.3
ICD-10 Finland
Open wound of other parts of foot
2.5
6.8
51
208
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.9
6.8
88
460
R06AE07
ATC
cetirizine; oral
1.3
6.8
834
7088
M81.4
ICD-10 Finland
Drug-induced osteoporosis
6.1
6.8
17
28
3044A
ICD-9 Finland
Drug dependence, Amphetamine and other psychostimulant dependence
40.2
6.8
8
*
3019
Kela drug reimbursment
Lenvatinib
40.2
6.8
8
*
L01EX02
ATC
sorafenib; oral
40.2
6.8
8
*
L17
ICPC
Foot/toe symptom/complaint
1.3
6.7
501
3978
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.8
6.7
113
648
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
3.4
6.7
30
89
N05AA02
ATC
levomepromazine; systemic
2.0
6.7
83
429
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.2
6.6
65
305
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.1
6.6
34
112
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
2.4
6.6
53
224
ZY010
NOMESCO Finland
Hospital outpatient
2.0
6.6
78
393
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.2
6.6
65
306
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.6
6.6
160
1017
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
6.6
718
6002
N05CF02
ATC
zolpidem; oral
1.4
6.6
335
2501
K25.4
ICD-10 Finland
Gastric ulcer, Chronic or unspecified with haemorrhage
3.9
6.6
25
65
130
Kela drug reimbursment
Malignant tumour
1.6
6.6
172
1116
F60.2
ICD-10 Finland
Dissocial personality disorder
8.7
6.5
13
15
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.1
6.5
66
312
B81
ICPC
Anaemia vit B12/folate deficiency
1.9
6.5
86
453
K86.01
ICD-10 Finland
Late effects of pancreatitis caused by alcohol
10.0
6.5
12
12
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
6.5
322
2391
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
2.5
6.5
49
200
K80
ICD-10 Finland
Cholelithiasis
3.2
6.5
31
97
SPAT1216
SPAT
Assessment of functional ability
1.4
6.5
324
2411
K31.7
ICD-10 Finland
Polyp of stomach and duodenum
5.7
6.4
17
30
H36.00
ICD-10 Finland
Diabetic background retinopathy
2.9
6.4
35
120
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
6.4
163
1048
5761A
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SUPPURATIVA]
70.0
6.4
7
*
0705A
ICD-9 Finland
Viral hepatitis, Other specified viral hepatitis without mention of hepatic coma
70.0
6.4
7
*
SPAT1281
SPAT
Other administrative function
1.6
6.4
155
986
A40.9
ICD-10 Finland
Streptococcal sepsis, unspecified
7.4
6.4
14
19
XX4BW
NOMESCO Finland
NA
7.4
6.4
14
19
S20
ICPC
Corn/callosity
2.4
6.4
49
204
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
14.3
6.4
10
7
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
3.6
6.4
26
72
K02.1
ICD-10 Finland
Caries of dentine
1.2
6.4
1087
9585
N02AC04
ATC
dextropropoxyphene; oral
1.9
6.3
85
453
N05AB01
ATC
dixyrazine; systemic
3.0
6.3
34
116
C07AB03
ATC
atenolol; systemic
1.7
6.3
128
776
5BA08
NOMESCO Finland
NA
5.2
6.3
18
35
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
4.2
6.3
22
53
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
6.0
6.3
16
27
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.7
6.3
116
686
GD1AD
NOMESCO Finland
Thorax CT examination
1.8
6.3
96
536
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
3.3
6.3
29
89
5710A
ICD-9 Finland
Chronic liver disease and cirrhosis, Alcoholic fatty liver
+∞
6.3
6
*
57100
ICD-8 Finland
Cirrhosis of liver, Cirrhosis cum alcoholismo
+∞
6.3
6
*
TJA00
NOMESCO Finland
Puncture of peritoneum
26.7
6.2
8
*
I78.8
ICD-10 Finland
Other diseases of capillaries
7.0
6.2
14
20
H03AA01
ATC
levothyroxine sodium; systemic
1.3
6.2
457
3620
RS221
NOMESCO Finland
NA
2.7
6.2
38
141
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
3.5
6.2
26
74
I73.0
ICD-10 Finland
Raynaud syndrome
2.8
6.2
36
128
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
2.8
6.2
36
128
318
Kela drug reimbursment
Teriparatide
5.0
6.2
18
36
P01BA02
ATC
hydroxychloroquine; oral
1.6
6.2
165
1079
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.9
6.2
91
500
SPC35
NOMESCO Finland
Production and attachment of single tooth bridge
2.8
6.2
37
135
N06AX03
ATC
mianserin; oral
1.8
6.2
97
547
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
4.5
6.2
20
45
H05AA02
ATC
teriparatide; parenteral
5.3
6.1
17
32
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
6.1
345
2620
H36.01
ICD-10 Finland
Diabetic maculopathy
2.9
6.1
33
113
310
Kela drug reimbursment
Orlistat, sibutramine and other major and expensive medicines used to treat obesity
2.9
6.1
33
113
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.5
6.1
45
185
N05BA12
ATC
alprazolam; oral
1.5
6.1
198
1352
A03FA01
ATC
metoclopramide; systemic, rectal
1.3
6.1
408
3187
J01CF05
ATC
flucloxacillin; systemic
1.9
6.1
79
417
K51
ICD-10 Finland
Ulcerative colitis
4.0
6.1
22
55
1280
FHL
Endoscopic retrograde cholangiography and pancreaticography
12.5
6.1
10
8
K77
ICPC
Heart failure
2.4
6.0
47
198
P19
ICPC
Drug abuse
4.9
6.0
18
37
K29.2
ICD-10 Finland
Alcoholic gastritis
6.7
6.0
14
21
D07XC01
ATC
betamethasone, combinations; topical
1.5
6.0
231
1634
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
3.0
6.0
32
109
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3033658) Prothrombin time (PT) actual/Normal
1492
5863
4.40
321.76
14.1
3.7
%
78.1
88.9
35.27
1448
5726
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
178
30
63.39
321.61
3.7
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
405
485
9.63
320.23
1.3
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
827
2117
5.16
310.64
13.0
7.2
mmol/l
11.4
10.0
5.01
804
2012
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
315
276
12.77
310.05
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
211
81
28.14
309.15
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
211
81
28.14
309.15
1.1
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
291
37
87.89
307.65
2.5
1.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
874
224
56.85
307.65
3.6
2.0
u/ml
1475.2
183.5
0.63
860
216
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
469
101
55.83
307.65
1.4
1.2
titre
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
969
2233
6.17
307.65
2.4
1.7
%
1.6
1.5
5.15
808
1941
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1295
3265
6.63
307.65
3.3
2.5
g/l
2.3
2.3
0.96
1210
3035
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1196
2103
9.32
307.65
1.6
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
224
83
29.30
307.65
1.1
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1325
3850
5.73
307.65
1.8
1.5
g/l
4.0
2.4
60.82
1133
2239
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
295
135
24.37
307.65
1.3
1.2
titre
212.5
69.6
2.03
55
23
(40768441) Liver Pathology biopsy report
497
93
65.08
307.65
2.0
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
882
377
34.04
307.65
5.9
1.7
umol/l
44.6
32.3
11.60
806
315
(3017143) Hepatitis C virus Ab [Presence] in Serum
1145
1903
9.63
307.65
1.6
1.5
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
399
95
49.00
307.65
1.1
1.0
mg/l
290.6
293.5
0.13
352
87
(3034770) Mitochondria Ab [Titer] in Serum
1178
364
56.06
307.65
1.4
1.1
titre
1159.7
732.9
—
175
7
(3028026) IgM [Mass/volume] in Serum or Plasma
1270
1126
20.18
307.65
1.8
1.9
g/l
1.9
1.4
4.87
1167
1026
(3007566) Smooth muscle Ab [Titer] in Serum
1173
361
56.11
307.65
1.4
1.1
titre
93.9
106.3
0.22
101
24
(3044007) Cell count panel - Peritoneal fluid
237
41
63.19
307.65
2.5
1.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2327
12026
7.24
307.65
19.5
6.0
umol/l
20.0
11.3
41.03
2298
11408
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
277
42
73.27
307.65
2.5
1.5
e6/l
12186.9
4181.2
0.57
157
25
(3037522) Nuclear Ab [Titer] in Serum
1301
2687
8.32
307.65
1.6
1.3
titre
875.3
549.2
4.41
380
554
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1205
2455
7.98
307.65
8.1
2.5
umol/l
13.8
7.8
10.81
1117
2161
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1662
2024
19.36
307.65
5.2
1.9
g/l
0.2
0.2
57.09
1531
1895
(3026692) Albumin [Mass/volume] in Peritoneal fluid
263
32
90.82
307.65
1.7
1.1
g/l
10.6
16.5
2.81
190
25
(3016650) Hepatitis A virus Ab [Presence] in Serum
326
257
14.26
307.65
1.1
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
604
192
40.08
307.65
1.2
1.1
g/l
1.6
1.5
3.80
545
178
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1292
3043
7.15
307.65
3.3
2.6
%
24.1
22.3
2.57
1140
2603
(3022948) Iron [Moles/volume] in Serum or Plasma
1329
3557
6.32
307.65
3.3
2.5
umol/l
13.0
12.7
0.45
1261
3303
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1961
7044
7.29
307.65
10.1
3.0
u/l
46.8
34.1
13.06
1909
6686
(3024561) Albumin [Mass/volume] in Serum or Plasma
2260
10047
8.17
307.65
13.5
4.6
g/l
33.1
35.3
59.37
2212
9330
(3005719) IgG [Mass/volume] in Serum or Plasma
1348
1467
17.14
307.65
2.6
2.9
g/l
13.3
10.3
52.92
1255
1343
(3023487) Leukocytes [#/volume] in Peritoneal fluid
305
43
79.70
307.65
2.7
1.8
e6/l
397.0
1089.4
1.56
216
34
(44816559) Phosphatidylethanol [Mass/volume] in Blood
415
303
15.97
307.65
1.9
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1962
9646
4.65
304.21
18.3
9.5
inr
1.3
1.3
0.63
583
2685
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
493
849
6.86
282.95
3.4
3.4
u/ml
54.1
5050.2
0.91
428
728
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
189
78
25.95
269.43
4.1
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
581
1280
5.49
256.23
1.4
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
307
345
9.90
253.39
1.4
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
942
3102
4.11
248.79
8.7
5.8
mmol/l
1.1
1.0
6.14
894
2861
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1528
7166
3.56
232.50
4.7
2.4
u/l
58.2
58.7
0.15
1455
6610
(4281824)
236
209
12.26
229.60
1.4
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1748
9029
3.59
225.45
4.7
2.8
ug/l
172.8
139.0
3.89
1662
8294
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1315
5793
3.44
217.73
3.5
2.2
mg/l
3.7
3.0
14.72
1206
4916
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1017
3839
3.62
214.93
5.3
3.3
mmol/l
0.8
0.8
18.77
967
3576
(3026250) Tacrolimus [Mass/volume] in Blood
161
79
21.59
213.84
35.4
30.8
ug/l
7.2
7.3
0.16
144
70
(3018677) aPTT in Platelet poor plasma by Coagulation assay
978
3638
3.63
210.81
3.1
2.0
s
31.9
29.8
17.26
942
3536
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
274
341
8.82
208.08
1.4
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
265
319
9.09
206.65
1.4
1.2
u/ml
348.0
261.6
2.51
157
190
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
227
223
11.01
205.75
1.3
1.1
u/l
47.0
55.3
1.44
161
157
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
295
410
7.94
204.18
8.4
5.0
iu/ml
785.2
694.8
0.09
71
58
(3042936) Bacteria identified in Isolate by Culture
913
3320
3.63
202.69
3.1
2.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
349
608
6.43
195.48
5.4
3.4
mg/l
1.8
1.6
3.93
331
555
(3024980) IgG subclass 4 [Mass/volume] in Serum
247
297
9.04
192.55
1.7
1.7
g/l
0.8
0.8
0.19
206
222
(40768797) Stomach Pathology biopsy report
876
3196
3.56
192.10
1.4
1.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
789
2696
3.71
191.27
3.3
4.3
u/l
240.4
244.2
0.31
760
2557
(42870588) Differential panel, method unspecified - Blood
1519
7712
3.18
191.00
9.4
5.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
274
380
7.90
189.72
1.5
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
132
53
26.12
189.51
1.8
5.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
251
318
8.59
187.53
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
751
2519
3.73
186.73
3.6
4.2
ug/l
4.8
25.1
4.16
636
2074
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
271
379
7.83
186.21
1.4
1.4
u/ml
25.5
18.7
—
5
8
(3006315) Basophils [#/volume] in Blood
1912
11212
3.34
184.74
10.0
5.7
e9/l
0.0
0.0
0.59
1717
9621
(3001604) Monocytes [#/volume] in Blood
1906
11160
3.33
184.55
10.0
5.7
e9/l
0.6
0.6
0.92
1707
9569
(3022096) Basophils/100 leukocytes in Blood
1792
10165
3.21
182.47
10.6
6.0
%
0.7
0.7
2.81
1727
9447
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2203
14164
3.85
181.18
11.7
2.9
u/l
155.6
48.5
111.99
2132
13060
(3019069) Monocytes/100 leukocytes in Blood
1825
10503
3.21
180.32
10.9
6.3
%
9.5
8.8
13.58
1761
9785
(3010375) cycloSPORINE [Mass/volume] in Blood
148
89
17.52
178.83
33.0
25.7
ug/l
123.1
117.2
0.30
125
74
(3006504) Eosinophils/100 leukocytes in Blood
1817
10462
3.19
178.74
10.6
5.9
%
3.1
2.9
3.08
1751
9703
(3019198) Lymphocytes [#/volume] in Blood
1923
11450
3.28
178.13
10.1
5.8
e9/l
1.7
1.9
3.61
1738
10012
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
178
151
12.54
177.44
1.1
1.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
249
336
8.05
176.29
1.4
1.4
u/ml
142.8
124.5
0.33
30
67
(3013115) Eosinophils [#/volume] in Blood
1932
11594
3.27
175.30
10.4
6.0
e9/l
0.2
0.2
0.64
1746
10106
(3048929) Epstein Barr virus Ab [Presence] in Serum
297
495
6.61
173.27
1.4
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1835
10750
3.15
172.54
10.8
6.1
%
25.9
27.4
7.35
1761
9953
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
343
662
5.78
172.13
2.2
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1928
11699
3.19
168.61
12.7
6.8
mmol/l
1.2
1.2
16.48
1677
9858
(3027945) Reticulocytes/100 erythrocytes in Blood
758
2740
3.44
165.70
3.2
2.5
%
2.2
1.8
14.45
692
2429
(3018010) Neutrophils/100 leukocytes in Blood
1800
10592
3.04
164.73
10.4
5.9
%
58.1
57.5
1.44
1732
9856
(3024471) HLA-A [Type]
121
57
22.16
163.12
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
120
56
22.37
162.40
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1016
4416
3.07
162.15
1.4
1.2
u/ml
1.7
1.4
0.26
220
1182
(3022217) INR in Platelet poor plasma by Coagulation assay
819
3171
3.26
159.22
19.5
26.5
inr
1.3
1.4
0.42
126
424
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
431
1080
4.55
158.85
2.0
1.8
g/l
1.1
1.6
19.09
364
939
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
324
638
5.63
158.73
4.3
2.3
g/l
2.8
3.7
18.70
318
606
(3002032) Base excess in Venous blood by calculation
641
2176
3.54
153.58
6.2
3.6
mmol/l
1.1
2.0
5.21
507
1752
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1788
10724
2.92
153.36
10.9
6.1
mmol/l
1.2
1.2
16.93
1704
9679
(3021447) Carbon dioxide [Partial pressure] in Venous blood
642
2184
3.53
153.29
6.2
3.6
kpa
5.6
5.8
9.15
624
2112
(3023368) Bacteria identified in Blood by Culture
1281
6502
2.82
150.98
6.6
4.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
425
1103
4.38
149.26
5.6
4.0
mmol/l
23.2
24.1
5.06
400
989
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
622
2111
3.52
148.66
4.1
2.3
u/l
31.9
40.0
2.09
563
1817
(3013650) Neutrophils [#/volume] in Blood by Automated count
2016
13129
3.03
143.91
13.3
9.0
e9/l
3.8
4.1
5.71
1850
11420
(3018418) pH of Serum or Plasma
1321
6942
2.75
143.56
6.2
4.1
ph
7.4
7.4
0.15
283
1319
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
271
511
5.78
138.67
3.0
3.4
u/ml
165.0
856.1
0.75
248
473
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
108
57
19.68
138.50
1.8
1.6
iu/ml
796071.4
2090600.0
—
7
5
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
143
129
11.64
136.70
1.4
1.1
u/l
142.3
73.8
5.12
131
112
(3000991) Gas panel - Venous blood
581
1996
3.43
135.16
12.3
8.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
211
321
7.04
133.66
2.8
2.8
u/ml
895.8
2077.5
0.43
11
22
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
139
125
11.66
133.13
1.4
1.1
u/l
33.2
14.2
2.78
126
107
(3023520) Reticulocytes [#/volume] in Blood
586
2045
3.37
132.73
3.4
2.6
e9/l
80.4
69.6
6.38
444
1564
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
142
137
10.88
129.69
1.8
1.5
u/l
8.1
6.0
0.36
84
66
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
159
181
9.26
128.73
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
160
189
8.93
125.83
2.4
2.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
127
113
11.74
122.41
3.8
2.1
umol/l
30.8
6.3
7.08
113
69
(3044640) Blood type and Crossmatch panel - Blood
1305
7314
2.50
117.38
4.3
2.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
661
2654
2.97
116.34
1.8
1.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
550
1993
3.20
115.81
1.9
2.8
g/l
66.8
66.3
0.62
509
1815
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1532
9281
2.48
115.53
3.8
2.2
nmol/l
74.8
78.3
5.12
1453
8234
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2369
17825
3.45
113.58
24.2
7.3
u/l
126.8
78.1
146.58
2338
16769
(3014576) Chloride [Moles/volume] in Serum or Plasma
715
3037
2.83
113.00
10.3
6.8
mmol/l
104.3
104.4
0.27
700
2969
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
487
1675
3.32
111.53
2.1
1.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
286
679
4.59
111.48
3.1
2.2
%
67.0
90.6
28.98
280
647
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
253
569
4.80
105.29
1.7
1.3
iu/ml
6.6
18.1
—
10
11
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
120
131
9.53
100.10
1.2
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
329
937
3.85
100.10
1.4
1.5
u/ml
12.4
24.0
0.52
17
20
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
105
98
11.10
97.90
1.9
1.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
283
738
4.16
97.26
1.7
1.6
titre
106.0
387.1
—
10
31
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1035
5651
2.34
93.38
4.1
2.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
253
626
4.35
93.13
3.3
2.4
%
221.0
195.6
3.65
245
601
(3014111) Lactate [Moles/volume] in Serum or Plasma
530
2107
2.88
93.11
10.3
7.0
mmol/l
1.8
1.3
8.31
510
2024
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
236
555
4.56
92.71
1.8
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
81
55
15.15
91.51
1.7
1.4
ug/l
10.9
8.2
3.57
81
55
(3013826) Glucose [Moles/volume] in Serum or Plasma
1927
13697
2.37
90.96
11.0
4.7
mmol/l
7.6
6.8
25.86
1861
12895
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
76
51
15.30
86.38
1.1
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
77
54
14.64
85.44
1.1
1.0
—
—
—
0
0
(3026782) Osmolality of Urine
865
4534
2.33
84.20
3.6
2.8
mosm/kgh2o
517.5
551.1
4.82
770
3864
(3036489) Thrombin time
283
836
3.66
81.08
3.0
2.0
s
24.2
21.4
6.54
267
750
(3016502) Oxygen saturation in Arterial blood
569
2525
2.58
79.46
11.2
7.7
%
95.7
95.6
0.13
547
2437
(3027801) Oxygen [Partial pressure] in Arterial blood
613
2825
2.51
79.00
10.8
7.3
kpa
11.7
12.2
1.84
587
2696
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
613
2825
2.51
79.00
10.8
7.3
kpa
4.8
5.1
9.86
587
2698
(3019309) Folate [Moles/volume] in Red Blood Cells
840
4448
2.28
78.96
2.0
1.8
nmol/l
1217.6
1174.4
0.59
680
3328
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
50
15
33.93
78.35
1.2
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
426
1668
2.84
75.93
1.7
2.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
445
1797
2.76
74.71
5.3
3.0
kpa
4.8
4.6
1.15
422
1732
(3002582) Erythrocytes [#/volume] in Urine
1151
7025
2.10
74.52
4.4
3.2
e6/l
146.5
76.8
0.34
935
5418
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
755
3904
2.29
74.44
2.2
1.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1051
6202
2.13
74.37
4.1
2.7
umol/l
3749.3
5305.0
0.56
931
5340
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1569
10756
2.07
73.82
7.0
4.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
273
837
3.51
73.72
3.5
3.0
u/ml
0.3
0.3
5.09
159
477
(3003396) Base excess in Arterial blood by calculation
600
2819
2.45
73.61
10.9
7.3
mmol/l
-0.1
1.2
8.10
480
2214
(3009343) pH of Capillary blood
391
1504
2.87
71.82
5.2
3.6
ph
7.4
7.4
0.42
54
187
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
721
3713
2.28
71.37
3.5
2.9
e6/l
2.9
2.1
1.40
431
2022
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
380
1448
2.89
70.99
5.1
3.6
mmol/l
0.8
1.9
4.12
265
1068
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
392
1525
2.83
70.43
5.2
3.6
kpa
4.8
5.2
10.27
374
1402
(3002173) Hemoglobin [Mass/volume] in Arterial blood
518
2328
2.51
69.62
12.0
8.1
g/l
111.2
121.6
21.20
499
2247
(3030467) Casts [#/volume] in Urine by Automated count
1066
6448
2.07
69.49
4.2
3.1
e6/l
0.6
0.4
2.00
858
4877
(3017181) Myelocytes/100 leukocytes in Blood
452
1911
2.64
68.94
5.3
4.1
%
0.6
0.9
1.25
168
562
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1433
9706
2.00
67.34
2.4
2.0
pmol/l
94.2
94.2
0.01
793
4979
(3021589) Normoblasts [#/volume] in Blood
1460
9956
2.00
67.26
19.2
9.7
e9/l
0.0
0.0
0.22
1248
8134
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
345
1285
2.93
67.02
12.8
9.5
mmol/l
23.5
24.4
4.63
326
1204
(3002179) Metamyelocytes/100 leukocytes in Blood
417
1728
2.67
66.04
5.0
3.9
%
0.5
0.6
0.47
118
398
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
346
1308
2.88
65.34
13.2
10.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
231
689
3.57
64.87
1.3
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
275
916
3.23
64.80
2.2
1.8
u/l
48.2
38.5
6.24
247
800
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
89
115
7.97
64.79
1.1
1.0
u/l
122.2
72.1
4.94
74
87
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
89
116
7.90
64.32
1.1
1.0
u/l
35.5
22.1
1.57
73
85
(3018095) Leukocytes [#/volume] in Urine
1241
8122
1.97
63.06
5.1
3.7
e6/l
92.8
105.9
0.30
968
5820
(4035726)
464
2072
2.49
62.72
1.7
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
424
1816
2.58
62.58
5.4
3.9
ng/l
103.0
91.5
1.21
384
1557
(40758558) Short blood count panel - Blood
968
5849
2.01
61.58
9.7
6.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
217
644
3.57
61.34
1.8
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1015
6258
1.99
60.78
4.2
3.1
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
109
191
5.90
59.68
1.2
1.5
g/l
9.9
6.6
4.47
80
130
(3024139) IgG subclass 3 [Mass/volume] in Serum
109
191
5.90
59.68
1.2
1.5
g/l
0.8
0.4
2.21
82
130
(3028192) IgG subclass 2 [Mass/volume] in Serum
109
191
5.90
59.68
1.2
1.5
g/l
3.2
3.0
0.77
82
130
(3021440) Promyelocytes/100 leukocytes in Blood
417
1814
2.53
59.39
5.4
4.1
%
0.1
0.1
1.88
159
517
(4062490)
109
194
5.81
58.72
1.2
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
925
5585
1.99
58.30
1.9
1.6
nmol/l
18.8
20.7
3.39
851
4745
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
717
3981
2.09
56.81
3.3
2.7
e6/l
1.8
1.1
0.78
426
2275
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
543
2721
2.24
55.84
2.0
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1157
7617
1.90
55.73
4.7
4.0
mg/mmol
17.2
8.0
4.51
825
4789
(3025159) Blasts/100 leukocytes in Blood
391
1699
2.52
55.61
5.4
4.2
%
0.5
0.3
0.16
131
436
(3013707) Erythrocyte sedimentation rate by Westergren method
2097
16830
2.05
54.11
7.4
4.1
mm/h
24.6
12.6
112.48
1993
15534
(3009508) Creatinine [Moles/volume] in Urine
1137
7498
1.88
54.01
4.1
3.1
mmol/l
6.8
7.5
5.47
961
6266
(3007853) Bacteria identified in Skin by Aerobe culture
527
2645
2.23
53.80
2.1
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
536
2715
2.21
53.46
2.1
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
806
4755
1.99
53.43
7.0
4.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1068
6923
1.89
53.35
4.0
3.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
825
4922
1.97
52.84
3.4
2.6
e6/l
6.4
5.2
1.33
743
4307
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
107
207
5.34
52.67
2.0
1.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
195
600
3.42
52.00
1.5
1.5
g/l
0.2
0.2
5.24
181
571
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
362
1564
2.51
51.93
13.8
8.9
%
0.6
0.7
1.38
362
1552
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
362
1572
2.50
51.34
13.7
8.8
%
1.5
1.3
2.15
362
1562
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
191
593
3.39
50.19
1.3
1.2
u/ml
34.9
41.6
0.16
13
32
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
197
625
3.32
50.00
1.5
1.5
g/l
1.2
1.2
0.48
184
594
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
160
443
3.77
50.00
1.3
1.2
u/ml
20.9
5.4
0.53
17
31
(3012516) Albumin [Mass/volume] in Urine
1092
7248
1.84
49.69
3.8
3.2
mg/l
462.4
273.7
0.72
785
4574
(3036481) Cortisol [Moles/volume] in Serum or Plasma
427
2029
2.31
49.38
2.1
2.2
nmol/l
362.6
372.3
0.29
404
1856
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
182
554
3.45
49.32
1.4
1.2
u/ml
33.3
3.8
1.03
32
52
(3000093) Morphology [Interpretation] in Blood Narrative
106
218
5.02
48.68
1.2
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
182
561
3.40
48.35
1.4
1.2
u/ml
6.4
8.2
0.18
37
94
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
218
757
3.04
47.51
1.6
3.6
ratio
1.9
2.4
0.21
18
60
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
251
943
2.83
47.44
1.6
2.6
g/l
7.2
7.4
0.87
175
721
(3022313) Gas panel - Capillary blood
278
1104
2.69
47.22
5.6
3.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
250
943
2.82
46.88
1.6
2.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
221
781
2.99
46.69
1.7
3.7
mg/l
59.5
70.7
0.24
180
640
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
249
943
2.80
46.33
1.6
2.6
g/l
4.4
3.8
6.05
170
689
(3034860) Kappa light chains.free [Mass/volume] in Serum
220
780
2.98
46.20
1.7
3.7
mg/l
70.8
62.2
0.35
179
638
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1065
7138
1.81
45.99
3.9
3.0
ng/l
2135.0
1427.4
2.83
956
6132
(40760888) Immunoglobulin light chains.free panel - Serum
181
583
3.25
44.76
1.6
3.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
146
414
3.67
44.02
1.4
1.4
mmol/l
51.1
62.0
2.50
104
335
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
478
2484
2.12
43.91
4.3
3.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
166
516
3.36
43.47
1.2
1.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
233
881
2.80
43.42
1.5
2.6
g/l
14.1
10.1
14.54
199
756
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
249
982
2.69
42.76
2.4
2.0
ug/l
1.6
2.2
0.50
223
869
(3031040) Bacteria [#/volume] in Urine by Automated count
1870
14933
1.80
42.62
6.1
4.6
e6/l
796.8
1860.1
0.88
31
231
(3015235) Bicarbonate [Moles/volume] in Capillary blood
181
609
3.11
41.58
3.6
3.2
mmol/l
23.3
24.9
3.90
163
525
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
143
420
3.54
40.89
1.3
1.2
u/ml
78.0
47.9
0.90
17
40
(3004119) Hemoglobin [Mass/volume] in Venous blood
320
1460
2.35
40.24
5.6
3.1
g/l
115.0
128.7
18.87
312
1423
(3039162) Centromere protein B Ab [Units/volume] in Serum
106
256
4.27
39.94
1.3
1.2
u/ml
96.1
56.4
0.88
17
15
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
226
884
2.70
39.37
1.6
2.7
g/l
3.1
3.1
0.03
176
706
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
769
4865
1.81
38.91
2.3
1.8
mg/l
2.3
1.2
6.99
666
3765
(3037467) Urinalysis macro (dipstick) panel - Urine
1911
15552
1.76
38.59
6.2
4.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
733
4621
1.80
37.27
4.5
3.8
ng/l
452.7
605.5
0.26
597
3751
(3042111) Morphology [Interpretation] in Bone marrow Narrative
137
416
3.41
37.20
1.6
1.5
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
75
145
5.29
36.94
1.5
1.3
promille
0.7
1.3
3.19
63
109
(1616796) Gas panel - Central venous blood
155
510
3.16
36.94
4.1
4.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
468
2562
2.00
36.77
1.7
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
148
475
3.24
36.76
1.6
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
332
1596
2.23
36.75
1.2
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
310
1452
2.28
36.52
1.9
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
139
434
3.32
36.11
3.2
2.9
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
66
116
5.81
36.01
2.3
1.8
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
128
382
3.47
35.70
3.3
3.6
%
1.1
1.5
0.66
99
298
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
299
1397
2.28
35.39
1.7
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
262
1158
2.40
35.24
6.2
3.1
mmol/l
24.3
25.3
3.04
252
1119
(3003434) Protein [Mass/volume] in Pleural fluid
116
328
3.65
35.11
1.8
1.5
g/l
27.9
32.5
2.72
105
292
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
373
1914
2.10
34.88
5.1
3.9
mmol/l
1.2
1.2
4.70
357
1664
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
142
462
3.19
34.48
1.3
1.2
—
11.0
—
0
5
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
154
527
3.04
34.31
1.5
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
438
2402
1.98
34.04
2.9
2.2
ug/g
177.2
144.1
1.09
369
1897
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
73
150
4.97
33.57
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
73
150
4.97
33.57
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
73
150
4.97
33.57
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
479
2729
1.92
33.20
1.9
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
394
2105
2.02
32.90
4.0
2.9
ng/l
267.9
202.6
1.93
366
1921
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
73
153
4.87
32.80
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
73
153
4.87
32.80
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
73
153
4.87
32.80
1.1
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
184
723
2.66
31.67
1.5
2.5
g/l
0.0
0.0
0.20
162
668
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
201
828
2.54
31.42
2.8
2.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
221
952
2.44
31.39
6.3
3.8
mmol/l
23.6
24.9
6.58
207
881
(3024928) Oxygen saturation in Venous blood
144
499
2.99
31.37
4.0
3.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
199
818
2.55
31.24
1.6
2.7
g/l
0.8
1.1
0.43
171
715
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
756
5028
1.70
30.83
1.9
1.7
pmol/l
11610405.4
33373895.0
0.89
646
4153
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
110
330
3.43
30.44
8.0
6.7
mg/l
12.4
11.9
0.57
97
309
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
65
133
4.98
30.05
1.5
1.3
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
173
678
2.66
29.92
1.5
2.5
g/l
0.0
0.0
0.50
152
625
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
185
753
2.56
29.63
1.5
2.4
g/l
35.0
37.8
6.67
159
650
(3023199) Leukocytes [#/volume] in Pleural fluid
105
312
3.46
29.49
1.8
1.4
e6/l
1453.5
1651.6
0.27
74
228
(3012441) Differential panel - Pleural fluid
94
260
3.71
29.40
1.8
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
220
975
2.37
29.30
6.6
5.5
%
1.8
1.6
2.78
204
915
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
133
459
2.99
29.18
1.3
1.6
nmol/l
0.9
0.8
1.24
107
381
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
170
669
2.64
29.16
1.5
2.5
g/l
0.0
0.0
0.00
150
624
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
24
14
17.29
28.97
1.0
1.0
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
47
74
6.44
28.63
2.7
2.1
u/ml
44578.9
5417.0
—
10
11
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
137
486
2.91
28.62
1.6
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
63
131
4.90
28.59
1.5
1.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
216
963
2.35
28.36
6.8
5.5
%
0.9
0.9
0.48
202
906
(3000570) Elastase.pancreatic [Mass/mass] in Stool
168
670
2.61
28.04
1.4
1.4
ug/g
284.7
283.5
0.02
98
405
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
192
828
2.42
27.15
2.5
2.3
ug/l
1035.2
746.4
0.33
179
783
(3028308) Erythrocytes [#/volume] in Pleural fluid
94
276
3.49
26.90
1.8
1.4
e6/l
18050.4
92831.0
1.81
53
169
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
148
570
2.69
26.48
2.3
1.9
mg/l
12.7
12.1
0.28
141
520
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
986
7238
1.57
26.00
2.6
2.1
u/l
216.0
220.1
0.05
940
6781
(3015377) Calcium [Moles/volume] in Serum or Plasma
1069
8001
1.55
25.80
3.8
3.4
mmol/l
2.3
2.4
6.35
946
6962
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
228
1082
2.21
25.77
4.6
2.6
%
0.7
0.7
0.27
222
1040
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
349
1942
1.91
25.54
3.2
2.8
ml/min/173m2
58.0
64.5
1.57
153
777
(3019060) Gas panel - Arterial blood
306
1647
1.97
24.67
6.8
4.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
84
243
3.53
24.61
1.9
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
146
583
2.59
24.30
1.7
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
88
269
3.35
23.68
1.8
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
182
819
2.31
23.34
3.0
3.1
g/l
0.3
0.3
0.29
107
329
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
50
102
4.97
23.23
1.5
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
50
102
4.97
23.23
1.5
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
165
714
2.40
23.14
4.9
3.4
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
55
123
4.54
22.91
1.3
1.3
nmol/l
1.2
1.1
0.22
45
94
(3008152) Bicarbonate [Moles/volume] in Arterial blood
287
1556
1.94
22.59
10.1
7.0
mmol/l
23.8
24.6
2.51
265
1455
(3035350) Ketones [Presence] in Urine by Test strip
1360
10947
1.48
22.01
4.6
3.7
estimate
0.0
0.0
0.00
300
2005
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
137
560
2.52
21.73
1.7
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
115
431
2.74
21.71
4.2
3.4
%
56.0
57.5
0.59
115
431
(3008757) Leukocyte morphology finding [Identifier] in Blood
84
266
3.23
21.38
3.6
4.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
126
501
2.59
21.17
3.3
2.6
%
14.7
16.2
3.42
75
253
(3012501) Base excess in Blood by calculation
130
525
2.55
21.15
5.5
4.9
mmol/l
2.2
2.6
0.73
83
366
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
113
426
2.72
21.10
1.6
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1352
10966
1.46
20.46
6.3
5.0
estimate
0.0
0.0
0.50
303
2043
(3029075) Extractable nuclear Ab panel - Serum
36
61
5.97
20.42
1.0
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
18
12
15.09
20.21
1.3
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
86
287
3.06
20.06
1.5
1.4
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
19
0
+∞
19.81
1.1
0.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
84
279
3.07
19.75
1.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
84
279
3.07
19.75
1.5
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1361
11100
1.45
19.72
4.7
3.8
estimate
0.0
0.0
1.08
270
1966
(3005988) Vibrio sp identified in Specimen by Organism specific culture
84
281
3.05
19.52
1.5
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
76
240
3.23
19.45
3.3
3.6
%
62.2
57.1
0.88
49
153
(3013945) Hepatitis B virus e Ab [Presence] in Serum
17
11
15.54
19.36
1.3
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
51
123
4.21
19.33
1.9
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
51
123
4.21
19.33
1.9
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
54
136
4.03
19.33
1.4
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1149
9105
1.45
19.25
5.3
3.7
ng/l
50.2
106.4
0.60
908
6564
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
123
507
2.49
19.19
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
123
507
2.49
19.19
1.5
1.3
—
—
—
0
0
(3010421) pH of Blood
142
625
2.34
19.17
5.8
4.6
ph
7.4
7.4
0.77
127
519
(3024522) Salmonella sp identified in Specimen by Organism specific culture
84
284
3.02
19.17
1.5
1.4
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
24
7
34.57
18.89
3.3
3.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
83
284
2.98
18.56
1.5
1.4
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
43
94
4.63
18.45
1.6
7.4
mg/l
57.2
71.1
0.77
32
68
(3047181) Lactate [Moles/volume] in Blood
158
742
2.20
18.29
7.9
6.7
mmol/l
1.7
1.3
1.21
136
655
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
30
48
6.31
18.01
1.1
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
55
148
3.77
17.98
1.1
1.2
mmol/l
35.2
33.7
0.17
50
128
(3025941) Bacteria identified in Stool by Culture
221
1188
1.94
17.75
1.3
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
122
520
2.41
17.72
2.8
2.2
g/l
117.6
130.1
4.75
97
378
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
91
338
2.75
17.52
1.6
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
75
251
3.04
17.44
1.2
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
77
264
2.97
17.17
1.4
1.2
—
—
—
0
0
(3019225) pH of Specimen
379
2415
1.66
17.11
7.2
4.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
65
202
3.27
17.11
1.1
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
23
29
7.99
17.03
1.7
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
69
226
3.11
16.66
1.2
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
87
325
2.73
16.58
2.6
2.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
132
602
2.25
16.42
2.5
2.3
ug/min
90.7
98.6
0.11
78
379
(40768804) Tissue Pathology biopsy report
1141
9237
1.40
16.02
2.6
2.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
57
171
3.38
15.88
1.2
1.1
u/ml
26.4
4.0
—
5
9
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
23
32
7.24
15.68
1.4
1.8
%
18.7
4.8
—
10
17
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
67
226
3.01
15.41
3.6
2.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
71
251
2.88
15.03
1.4
2.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
102
434
2.40
14.91
1.1
1.3
miu/ml
205.4
203.4
0.02
25
180
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
134
641
2.15
14.84
1.7
1.6
iu/ml
0.1
10.9
0.57
29
124
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
57
179
3.23
14.79
1.2
1.1
u/ml
39.0
62.9
—
5
8
(3001893) Eosinophils/100 leukocytes in Pleural fluid
34
74
4.64
14.70
1.5
1.6
%
2.7
3.1
0.09
24
63
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
42
108
3.93
14.67
1.1
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
57
180
3.21
14.66
1.2
1.1
u/ml
76.0
37.7
0.83
15
15
(3038026) Centromere Ab [Units/volume] in Serum
58
186
3.16
14.54
1.3
1.1
u/ml
77.8
82.8
—
8
8
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
64
220
2.95
14.26
1.3
1.3
nmol/l
1.6
1.5
0.30
57
195
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
72
266
2.75
14.06
1.6
1.7
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
34
77
4.46
14.01
1.3
1.6
umol/l
95.2
117.1
—
9
46
(4198724)
27
50
5.44
14.00
9.7
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
151
774
2.01
13.92
1.7
1.6
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
19
25
7.65
13.56
1.1
1.2
u/l
13.2
24.3
0.80
14
15
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
169
911
1.91
13.46
2.2
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
181
1000
1.87
13.37
2.6
1.9
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
38
98
3.92
13.24
2.4
2.5
u/ml
2083.1
1293.1
0.43
38
98
(3000012) Reticulocyte production index
41
112
3.70
13.19
2.3
1.5
—
—
—
0
0
(3000492) Spirometry study
317
2057
1.61
13.16
1.5
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
210
1223
1.78
13.06
3.4
2.8
e6/l
0.3
0.3
0.08
205
1193
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
65
237
2.79
13.04
1.1
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
47
142
3.35
13.00
4.2
3.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
70
269
2.64
12.70
3.6
2.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
688
5280
1.40
12.51
4.0
3.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2392
22408
1.54
12.24
38.8
14.8
mg/l
19.8
24.8
20.75
2266
17863
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
35
91
3.88
12.08
1.5
1.5
%
62.7
60.3
0.13
27
72
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
20
32
6.29
12.01
1.9
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
65
1532
0.41
11.99
1.4
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
29
66
4.43
11.90
1.7
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
748
5875
1.38
11.71
1.6
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
64
247
2.63
11.54
4.2
3.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
589
4459
1.41
11.45
3.3
3.0
mmol/l
2.5
2.5
10.93
506
3921
(44790048)
68
276
2.50
11.08
1.7
1.5
—
—
—
0
0
(44806118)
68
276
2.50
11.08
1.7
1.5
—
—
—
0
0
(44790049)
68
276
2.50
11.08
1.7
1.5
—
—
—
0
0
(44790047)
68
276
2.50
11.08
1.7
1.5
—
—
—
0
0
(3039000) Anion gap in Blood
109
540
2.06
11.08
9.4
7.6
mmol/l
11.2
11.3
0.03
97
487
(3018572) Chloride [Moles/volume] in Blood
109
540
2.06
11.08
9.4
7.6
mmol/l
105.1
105.4
0.25
97
487
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
28
66
4.28
11.01
1.3
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
90
418
2.19
10.81
1.6
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
421
3034
1.46
10.66
1.3
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
727
5772
1.35
10.42
4.6
3.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
53
196
2.74
10.42
2.1
2.2
ml
745.8
642.7
0.64
32
135
(3000919) Neutrophils/100 leukocytes in Pleural fluid
28
69
4.09
10.41
1.3
1.5
%
22.7
26.9
0.28
23
64
(40768443) Skin Pathology biopsy report
172
1014
1.74
10.28
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
107
544
2.01
10.16
1.3
1.2
—
—
—
0
0
(3013512) EKG study
865
7071
1.33
10.12
5.2
4.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
82
1658
0.48
10.10
1.5
1.8
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
25
58
4.34
10.04
1.2
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
74
327
2.30
10.03
1.4
1.5
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
15
9
16.75
9.87
1.3
1.0
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
60
243
2.50
9.86
1.3
1.4
mosm/kgh2o
276.7
277.2
0.05
50
179
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
77
349
2.24
9.84
1.1
1.1
iu/ml
206.8
78.5
0.35
12
69
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
21
43
4.91
9.78
1.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
23
52
4.45
9.54
2.0
2.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
80
374
2.17
9.49
1.2
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
79
368
2.18
9.46
1.5
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
103
533
1.97
9.33
1.1
1.1
u/ml
4.6
4.2
—
5
52
(3028707) Methadone [Presence] in Urine by Screen method
46
169
2.75
9.19
7.7
1.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
30
86
3.52
9.07
1.4
1.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
35
111
3.18
9.04
2.2
2.5
mmol/l
8.5
9.8
1.13
24
86
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
73
336
2.20
9.02
1.5
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
16
28
5.74
8.80
1.5
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
77
366
2.14
8.79
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
47
180
2.64
8.69
1.2
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
33
104
3.20
8.63
2.4
2.4
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
18
36
5.03
8.61
2.0
2.8
mg/l
14.1
23.7
—
5
8
(3048879) Bone marrow aspiration report
26
70
3.74
8.61
1.2
1.8
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
96
501
1.95
8.51
3.5
3.2
nmol/l
0.8
0.8
0.13
67
388
(3045142) Bone marrow Pathology biopsy report
64
286
2.27
8.51
1.4
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
609
7530
0.75
8.40
3.9
3.0
—
—
—
0
0
(3017704) Immunofixation for Urine
41
149
2.78
8.39
1.3
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
549
6886
0.75
8.38
3.3
4.4
%
23.3
21.7
1.16
223
3448
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
48
190
2.55
8.32
1.7
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
375
4983
0.71
8.31
2.4
3.1
ug/l
0.7
0.8
0.25
259
3387
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
46
179
2.60
8.26
1.4
1.5
u/ml
28.3
26.1
0.11
12
32
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
57
246
2.35
8.22
1.6
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
60
266
2.28
8.14
1.6
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
47
190
2.50
7.82
1.5
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
48
1072
0.44
7.79
1.4
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
194
1271
1.57
7.72
2.4
2.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
82
420
1.98
7.71
4.3
3.2
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
16
32
5.02
7.66
1.2
1.1
%
87.4
80.1
—
8
9
(40768446) Kidney Pathology biopsy report
27
82
3.32
7.51
1.4
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
30
98
3.08
7.43
1.3
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
33
114
2.92
7.43
2.5
2.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
35
125
2.82
7.43
3.9
2.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
265
1871
1.46
7.40
4.9
4.1
—
—
—
0
0
(3036603) Volume of Urine
39
148
2.66
7.39
1.7
1.4
ml
1930.3
1849.5
—
9
31
(1761482) Bacteria [#/volume] in Urine by Culture
105
592
1.80
7.38
6.1
4.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
58
266
2.21
7.30
13.3
5.3
mmol/l
8.8
7.3
1.81
47
221
(3008116) Ketones [Moles/volume] in Urine by Test strip
18
42
4.31
7.21
1.3
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
34
122
2.81
7.16
3.1
3.5
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
22
61
3.63
7.02
1.5
1.5
ug/l
0.4
0.4
0.24
16
33
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
14
27
5.21
6.97
1.1
1.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
16
36
4.46
6.70
1.8
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
298
2189
1.41
6.70
2.6
2.4
ug/l
9.5
7.1
0.58
262
1932
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
14
28
5.02
6.70
2.1
2.2
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
23
68
3.40
6.69
1.5
2.2
%
318.6
167.4
2.56
23
63
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
15
32
4.71
6.68
1.2
1.1
%
78.0
73.9
—
7
8
(3035637) Corticotropin [Mass/volume] in Plasma
59
283
2.11
6.67
1.4
1.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
77
407
1.92
6.66
1.3
1.2
u/l
49.2
37.1
0.38
70
348
(3026389) Candida sp identified in Specimen by Organism specific culture
60
290
2.09
6.65
1.7
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
126
772
1.66
6.63
6.6
3.9
mmol/l
4.0
3.9
0.75
118
726
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
40
164
2.46
6.52
1.2
1.2
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
13
25
5.22
6.49
1.2
1.4
%
16.6
19.5
—
5
17
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
14
29
4.85
6.45
2.1
2.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
24
75
3.22
6.42
1.3
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
33
124
2.68
6.41
2.0
2.3
—
—
—
0
0
(3019977) pH of Arterial blood
34
130
2.64
6.39
3.4
2.8
ph
7.4
7.4
0.62
14
45
(3016750) Collection duration of Urine
38
154
2.49
6.35
2.1
2.0
min
496.5
493.1
0.06
23
116
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
968
8401
1.24
6.27
5.2
4.0
—
—
—
0
0
(3020891) Body temperature
154
1006
1.56
6.25
8.4
4.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
33
126
2.64
6.22
1.7
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
33
126
2.64
6.22
1.7
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
33
126
2.64
6.22
1.7
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
33
126
2.64
6.22
1.7
1.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
47
212
2.24
6.20
1.6
2.3
e9/l
0.8
1.2
2.24
27
126
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
48
219
2.21
6.17
1.6
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
48
219
2.21
6.17
1.6
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
48
219
2.21
6.17
1.6
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
107
642
1.69
6.12
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
106
636
1.69
6.06
1.2
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
43
189
2.30
6.04
1.8
2.6
%
8.4
11.4
4.44
43
189
(42529406) Shigella sp [Presence] in Stool by Culture
107
647
1.68
5.95
1.2
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
30
112
2.70
5.92
3.5
4.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
37
154
2.42
5.87
2.2
2.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
59
298
2.00
5.85
7.5
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
30
113
2.67
5.82
1.1
1.7
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
11
20
5.52
5.80
1.1
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
162
1090
1.52
5.77
2.3
3.7
u/ml
171.3
66.3
1.99
151
1052
(3043410) Blood group antigens tested for on Red Blood Cells
22
70
3.16
5.74
1.6
1.9
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
31
120
2.60
5.71
1.3
1.2
nmol/l
126.2
138.2
0.76
31
120
(3008536) Aspergillus sp Ab [Presence] in Serum
18
51
3.55
5.60
1.3
1.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
61
320
1.93
5.45
1.5
1.2
u/ml
3.0
2.9
0.03
36
97
(3011288) Drugs identified in Urine by Screen method
52
258
2.04
5.44
11.2
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
60
314
1.93
5.41
1.6
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
37
161
2.32
5.35
1.3
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
173
1201
1.47
5.32
5.0
3.4
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
17
49
3.48
5.17
1.5
1.2
mmol/l
1.3
1.8
1.12
11
35
(4146454)
51
259
1.99
5.03
2.9
2.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1946
18327
1.21
4.93
47.4
18.1
%
14.9
13.7
121.79
1933
17887
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
58
312
1.88
4.85
1.5
1.2
u/ml
4.0
5.1
0.30
36
135
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
18
57
3.17
4.76
7.6
7.0
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
18
57
3.17
4.76
1.3
1.3
%
77.1
91.9
0.72
12
30
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
13
33
3.95
4.71
12.0
13.5
mmol/l
4.4
5.5
1.44
13
33
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
18
58
3.12
4.63
1.3
1.1
%
81.3
90.0
0.57
12
30
(3027008) Opiates [Presence] in Urine
68
392
1.75
4.57
3.8
1.7
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
11
25
4.41
4.56
1.1
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
68
393
1.75
4.53
6.9
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
64
364
1.78
4.51
7.3
1.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
175
1258
1.42
4.51
1.3
1.3
u/ml
243.0
212.3
0.30
158
1157
(3045424) Erythrocytes [Presence] in Urine
68
394
1.74
4.49
1.5
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
68
394
1.74
4.49
7.5
1.7
—
—
—
0
0
(4306422)
55
301
1.84
4.39
1.4
1.2
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
19
66
2.89
4.33
1.3
1.2
ug/l
13.3
509.2
—
8
32
(3026361) Erythrocytes [#/volume] in Blood
2408
24747
0.78
4.30
56.7
21.9
e12/l
4.1
4.5
129.37
2360
23996
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
25
101
2.49
4.29
1.9
1.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34
158
2.17
4.27
1.4
1.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
2408
24745
0.78
4.27
56.4
21.8
pg
30.6
30.4
5.18
2387
24353
(3010813) Leukocytes [#/volume] in Blood
2409
24751
0.78
4.24
56.7
21.9
e9/l
6.6
6.7
1.34
2363
24002
(3029937) Albumin [Presence] in Urine by Test strip
691
5990
1.21
4.22
5.3
4.2
estimate
0.0
0.0
0.88
278
1955
(3000963) Hemoglobin [Mass/volume] in Blood
2410
24753
0.78
4.15
57.2
22.0
g/l
124.1
135.2
159.87
2392
24362
(3024731) MCV [Entitic volume]
2409
24743
0.78
4.14
56.5
21.8
fl
92.4
91.3
18.02
2388
24354
(3027944) Amphetamines [Presence] in Urine
66
389
1.71
4.14
6.1
1.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2409
24739
0.78
4.09
56.7
21.9
e9/l
200.6
248.1
124.68
2367
24075
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
16
52
3.09
4.08
2.4
8.4
%
53.8
76.3
—
9
40
(3001019) Free T4 and TSH panel - Serum or Plasma
51
891
0.56
4.07
1.5
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
170
2295
0.72
4.05
1.6
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
24
99
2.44
3.97
1.9
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
24
99
2.44
3.97
1.9
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
136
960
1.44
3.91
1.4
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
46
248
1.87
3.89
1.1
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
10
24
4.18
3.88
1.2
1.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
16
54
2.97
3.84
7.6
7.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
22
496
0.44
3.82
1.1
1.7
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
9
15
6.02
3.81
1.0
1.1
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
6
5
12.02
3.76
1.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
55
318
1.74
3.72
4.0
2.9
—
—
—
0
0
(3025315) Body weight
9
16
5.64
3.65
5.2
4.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
46
254
1.82
3.63
4.1
3.8
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
13
40
3.26
3.62
1.1
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
30
143
2.11
3.59
1.3
1.3
mmol/l
12.8
11.9
0.30
18
47
(3001964) Herpes simplex virus Ag [Presence] in Specimen
18
68
2.66
3.56
1.7
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
32
157
2.05
3.55
2.0
2.2
e6/l
612.4
643.9
0.09
16
68
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
21
86
2.45
3.55
1.2
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
33
164
2.02
3.54
1.6
2.3
%
13.5
12.6
0.11
14
66
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
10
26
3.86
3.52
1.0
1.3
mmol/l
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
10
26
3.86
3.52
1.0
1.3
mmol/l
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
6
6
10.02
3.49
1.0
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
199
1526
1.33
3.49
3.2
3.3
e9/l
3.9
4.1
0.71
144
1163
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
19
75
2.54
3.46
1.0
1.1
miu/ml
1604.4
1504.0
0.19
19
75
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1346
12495
1.15
3.35
2.9
2.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
14
48
2.93
3.30
1.0
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
768
8566
0.86
3.28
3.9
5.0
ug/l
2.2
3.5
1.35
676
7680
(4268621)
39
212
1.85
3.26
2.8
2.2
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
6
7
8.59
3.26
1.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
6
7
8.59
3.26
1.0
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
28
136
2.07
3.22
1.4
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
28
136
2.07
3.22
1.4
1.7
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
8
15
5.35
3.19
1.3
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1789
16978
1.16
3.19
4.3
4.0
pmol/l
14.8
14.9
0.65
1651
15312
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
51
303
1.70
3.18
1.3
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
38
207
1.85
3.17
1.3
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
94
647
1.47
3.14
1.4
1.6
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
8
16
5.01
3.05
1.0
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
27
133
2.04
3.01
3.1
2.8
%
36.8
37.6
0.07
12
41
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
11
35
3.15
2.93
2.6
1.4
ng/l
134.9
120.7
0.11
11
35
(3009214) Lutropin [Units/volume] in Serum or Plasma
68
445
1.54
2.91
1.5
1.3
u/l
12.7
10.5
0.40
51
355
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
23
108
2.14
2.90
1.1
1.1
ratio
1.1
1.0
—
10
33
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
6
9
6.68
2.87
2.2
4.4
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
6
9
6.68
2.87
4.2
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
28
144
1.95
2.80
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
52
325
1.61
2.72
2.0
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
140
1062
1.34
2.71
2.1
1.9
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
28
146
1.93
2.70
1.2
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
23
112
2.06
2.67
1.5
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
39
228
1.72
2.63
1.7
1.7
—
1220.0
—
0
8
(4015189)
17
74
2.31
2.58
3.3
2.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
16
68
2.36
2.55
1.5
2.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2151
22158
0.86
2.53
5.7
4.6
mmol/l
1.4
1.5
19.96
2001
20276
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
432
3752
1.18
2.52
1.3
1.3
iu/ml
44.4
37.4
0.37
134
1196
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
44
270
1.64
2.50
1.8
1.8
u/l
5918.7
2456.7
0.24
11
104
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2119
20487
1.15
2.48
5.4
4.7
mu/l
2.2
2.1
0.52
1989
18574
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
45
279
1.62
2.46
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2169
22318
0.86
2.44
5.9
4.6
mmol/l
4.3
4.6
35.96
2036
20558
(44806420)
16
70
2.29
2.41
2.6
2.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2220
22794
0.86
2.37
6.2
5.2
mmol/l
2.4
2.7
41.62
2068
20879
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
349
2999
1.19
2.31
1.4
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
188
1518
1.26
2.31
3.5
3.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
18
85
2.13
2.28
1.2
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
11
41
2.69
2.27
7.0
7.9
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
21
106
1.99
2.25
1.0
1.0
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
45
287
1.58
2.22
1.6
1.4
mu/l
164.6
41.3
0.81
40
255
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
5
9
5.56
2.21
1.0
1.3
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
8
24
3.34
2.18
2.3
2.9
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
8
24
3.34
2.18
1.0
2.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
8
24
3.34
2.18
1.1
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
15
67
2.25
2.17
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
57
825
0.68
2.15
1.1
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
66
463
1.44
2.10
1.5
1.5
pmol/l
117.9
239.3
1.85
61
456
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
8
25
3.21
2.09
1.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
75
540
1.40
2.07
1.3
1.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
9
31
2.91
2.07
2.1
1.7
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
10
5.01
2.07
1.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
18
89
2.03
2.05
3.4
2.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
13
56
2.33
2.04
2.7
3.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
15
4.01
2.04
1.0
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2404
23546
1.17
2.01
45.0
17.2
mmol/l
138.3
139.7
84.54
2376
22969
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
25
140
1.79
2.00
2.3
2.1
ug/min
230.3
195.2
—
7
30
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
11
4.55
1.94
3.0
3.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
15
71
2.12
1.92
3.2
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
15
71
2.12
1.92
3.2
2.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
122
961
1.28
1.88
2.6
2.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
20
107
1.88
1.86
6.5
14.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
681
6241
1.12
1.83
1.9
1.7
mmol/l
1.5
1.4
2.38
611
5186
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
12
4.17
1.82
4.4
10.9
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
12
4.17
1.82
1.0
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
54
377
1.44
1.80
1.5
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
52
736
0.70
1.79
2.4
1.7
mg/l
5.4
3.9
0.63
44
527
(3025130) Human papilloma virus identified in Specimen
30
184
1.64
1.78
2.4
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2170
21148
1.13
1.77
9.8
6.0
mmol/mol
43.1
40.2
20.94
2059
19471
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
41
272
1.52
1.76
1.2
1.4
pmol/l
391.3
290.5
0.51
33
214
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
7
24
2.92
1.72
1.0
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
32
202
1.59
1.71
2.3
2.1
u/field
1.6
1.9
0.17
16
83
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
11
48
2.30
1.70
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
43
291
1.49
1.69
1.1
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
10
42
2.39
1.67
1.0
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
28
172
1.63
1.67
2.0
2.0
mmol/l
7.7
7.1
0.41
21
108
(3044889) 12 lead EKG panel
1704
16420
1.10
1.65
4.7
4.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
72
538
1.35
1.65
1.2
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2404
23605
1.15
1.65
45.2
17.4
mmol/l
4.0
4.0
1.46
2376
22992
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
49
2.25
1.63
2.2
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
19
105
1.82
1.63
1.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
12
56
2.15
1.61
1.1
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
12
56
2.15
1.61
1.9
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
128
1.72
1.60
1.2
1.1
—
—
—
0
0
(4024509)
35
230
1.53
1.59
1.7
1.6
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
32
2.50
1.59
1.1
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
38
555
0.68
1.58
1.1
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
27
167
1.62
1.58
2.3
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
156
0.45
1.55
1.6
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
15
78
1.93
1.54
2.0
2.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
13
64
2.04
1.54
2.5
1.5
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
8
33
2.43
1.53
1.1
1.3
—
—
—
0
0
(4010399)
197
1678
1.19
1.51
1.4
1.4
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
21
2.86
1.50
1.3
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
38
259
1.47
1.48
1.0
1.1
u/ml
2.3
2.4
—
10
103
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
17
94
1.81
1.47
1.1
1.1
iu/ml
213.2
212.7
0.00
17
94
(3004451) EKG impression Narrative
21
124
1.70
1.47
1.3
1.3
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
28
2.50
1.45
1.1
1.6
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
34
228
1.50
1.44
5.2
3.0
mg/l
79.0
37.7
0.57
25
168
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
66
1.97
1.43
1.0
1.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
41
286
1.44
1.43
1.3
1.6
%
68.9
59.8
0.80
25
178
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
16
88
1.82
1.41
1.1
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
40
2.25
1.40
1.6
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
68
519
1.32
1.39
4.4
3.6
mg/l
28.2
27.1
0.07
47
315
(21494814) CD8 cells/100 lymphocytes in Specimen
17
96
1.78
1.39
1.8
2.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
11
53
2.08
1.38
5.0
2.3
mmol/l
9.3
8.2
—
6
29
(3021788) Differential panel - Synovial fluid
58
433
1.35
1.38
1.5
1.6
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
12
60
2.00
1.38
1.8
1.0
pmol/l
408.7
263.5
—
7
44
(3013139) Helicobacter pylori Ag [Presence] in Stool
173
1473
1.19
1.36
1.2
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
270
3052
0.87
1.36
14.1
7.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
37
525
0.70
1.36
1.4
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
146
0.48
1.32
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
146
0.48
1.32
1.4
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
15
83
1.81
1.31
1.1
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
24
2.50
1.30
1.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
40
284
1.41
1.29
1.1
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
23
145
1.59
1.29
3.2
2.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
18
2.78
1.28
1.4
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
228
2004
1.15
1.22
4.3
3.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
117
972
1.21
1.22
1.7
1.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
10
49
2.04
1.22
1.2
1.4
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
19
2.63
1.21
1.0
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
19
2.63
1.21
1.0
1.1
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
8
37
2.17
1.21
1.1
1.5
pmol/l
36.8
46.8
—
8
32
(3019150) Specific gravity of Urine by Refractometry
524
4843
1.10
1.21
5.4
4.2
kg/l
1.0
1.0
0.30
103
711
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
145
0.48
1.19
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
145
0.48
1.19
1.4
1.4
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
6
26
2.31
1.18
1.0
1.5
nmol/l
0.1
0.1
—
6
15
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
26
2.31
1.18
2.0
2.8
u/field
1.0
0.5
—
6
26
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
34
0.00
1.16
0.0
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
20
2.50
1.15
1.4
1.4
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
13
72
1.81
1.15
4.8
2.0
ug/l
2.5
1.3
0.56
13
66
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
12
65
1.85
1.13
1.3
1.2
g/l
0.3
0.3
—
7
52
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
42
311
1.36
1.10
2.8
2.3
mg/l
23.0
22.9
0.01
13
75
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
14
81
1.73
1.09
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
128
1.57
1.08
1.1
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
10
52
1.93
1.06
1.1
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
18
113
1.60
1.05
1.3
1.7
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
33
2.12
1.05
1.0
1.2
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
22
2.27
1.03
1.8
1.3
u/l
9.0
15.6
—
5
22
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
35
2.00
1.00
1.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
20
131
1.53
0.99
1.8
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
80
656
1.23
0.99
1.3
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
31
223
1.39
0.98
1.5
1.5
%
25.7
31.3
0.33
18
138
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
1.2
—
22.6
—
0
21
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
30
0.00
0.97
0.0
1.2
—
2.0
—
0
30
(3000060) B lymphocytes [#/volume] in Blood
10
54
1.85
0.96
1.4
2.3
e6/l
184.0
211.7
—
5
23
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
23
157
1.47
0.96
1.3
1.3
u/ml
1.4
1.4
0.00
14
76
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2109
21452
0.93
0.94
5.3
4.1
mmol/l
1.3
1.3
1.67
1961
19469
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
39
295
1.33
0.92
1.3
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
70
1.72
0.92
1.4
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
391
3617
1.09
0.91
1.3
1.2
u/ml
14.5
12.9
0.14
141
1375
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
147
1285
1.15
0.91
2.3
3.3
pmol/l
4.0
4.4
4.49
129
1128
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2176
22098
0.93
0.90
5.9
4.8
mmol/l
6.6
6.0
34.62
2015
20037
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
129
0.54
0.88
1.4
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
31
1.94
0.84
1.0
2.3
umol/l
15.6
18.9
—
6
31
(4094501)
54
668
0.80
0.84
1.1
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
8
45
1.78
0.84
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
36
275
1.31
0.82
1.3
1.3
nmol/l
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
6
32
1.88
0.81
1.2
1.0
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
8
47
1.70
0.80
1.1
1.4
—
127.3
—
0
9
(3006270) Folate [Moles/volume] in Blood
25
181
1.38
0.79
1.4
1.2
nmol/l
251.5
370.1
1.76
16
161
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
10
58
1.73
0.79
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
10
58
1.73
0.79
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
10
58
1.73
0.79
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
10
58
1.73
0.79
1.1
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
66
1.67
0.78
1.3
1.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
15
98
1.53
0.78
2.0
1.2
%
—
69.6
—
0
14
(3034426) Prothrombin time (PT)
12
74
1.62
0.78
1.9
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
125
0.56
0.77
1.4
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
126
0.55
0.77
1.4
1.3
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
34
1.77
0.76
1.0
1.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
13
83
1.57
0.75
1.0
1.1
u/ml
0.4
1.3
—
6
30
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
54
1.67
0.74
1.0
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
7
38
1.84
0.73
1.1
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
40
1.75
0.71
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
146
1306
1.12
0.69
1.2
1.2
iu/ml
134.4
158.1
0.27
43
477
(3051101) Glucose [Moles/volume] in Cord blood
7
43
1.63
0.66
18.3
5.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
72
614
1.18
0.66
1.4
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
19
137
1.39
0.64
1.5
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
68
579
1.18
0.64
1.5
1.7
e6/l
14786.6
14251.9
0.03
42
411
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
14
95
1.48
0.64
15.2
11.6
mmol/l
0.6
0.6
0.07
14
89
(3017446) Testosterone [Moles/volume] in Serum or Plasma
152
1679
0.90
0.62
2.0
2.2
nmol/l
13.4
12.8
0.29
141
1470
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2165
21380
1.06
0.61
34.8
14.0
ml/min/173m2
75.7
78.1
4.46
1940
17688
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
63
1.59
0.61
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
105
0.57
0.61
2.0
1.6
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
30
1.67
0.61
2.2
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
139
0.65
0.60
1.1
1.0
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
20
0.00
0.60
0.0
2.3
—
1.6
—
0
14
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
140
0.64
0.60
5.6
6.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
20
148
1.35
0.59
2.3
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
52
436
1.20
0.59
1.4
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
28
219
1.28
0.58
1.2
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
13
185
0.70
0.58
1.0
1.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
15
208
0.72
0.58
3.7
4.8
u/ml
22.8
50.5
—
6
56
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
91
1029
0.88
0.56
1.1
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
87
0.57
0.56
1.8
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
65
1.54
0.55
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
148
0.67
0.55
1.4
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
46
547
0.84
0.55
1.3
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
8
126
0.63
0.54
1.6
1.3
—
1.5
—
0
8
(4034850)
66
758
0.87
0.52
17.9
9.6
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
9
63
1.43
0.52
1.4
1.3
%
102.9
108.2
—
9
55
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
9
63
1.43
0.52
1.0
1.2
%
—
9.7
—
0
9
(3005570) Glucose [Moles/volume] in Urine
29
233
1.25
0.51
2.3
2.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
13
92
1.42
0.50
3.2
1.9
ug/l
19.2
103.6
0.50
13
83
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
16
118
1.36
0.50
8.1
5.9
u/ml
186.1
49.1
—
7
29
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
271
2883
0.93
0.50
1.4
1.4
—
—
—
0
0
(4027681)
7
108
0.65
0.48
1.3
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
7
109
0.64
0.48
19.0
12.1
nmol/l
920.7
856.3
—
7
104
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
46
1.52
0.48
31.6
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2021
19969
1.05
0.48
42.0
16.0
%
36.2
39.5
39.15
1390
13669
(40768795) Lymph node Pathology biopsy report
27
217
1.25
0.48
1.4
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
13
176
0.74
0.46
1.5
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
198
0.76
0.45
1.1
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
25
201
1.25
0.45
1.5
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
64
563
1.14
0.44
2.7
2.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
27
220
1.23
0.43
1.3
1.3
u/l
38.6
31.5
0.31
21
178
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
8
56
1.43
0.42
4.9
4.0
mg/l
5.4
7.2
—
8
50
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
32
1.56
0.42
1.6
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
32
1.56
0.42
1.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
13
96
1.36
0.41
1.2
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.2
—
0
6
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.3
—
18.0
—
0
9
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.3
—
43.0
—
0
9
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
39
334
1.17
0.39
1.1
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
22
270
0.81
0.39
1.6
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
113
1228
0.92
0.38
1.7
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
72
647
1.12
0.38
1.4
1.4
iu/l
29.6
32.9
0.39
63
549
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
69
1.31
0.37
1.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
42
1.43
0.35
1.5
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
15
117
1.28
0.35
1.1
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
44
1.36
0.34
1.3
3.0
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
27
318
0.85
0.33
4.1
4.8
umol/l
327.8
357.0
0.72
22
279
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
47
1.28
0.32
1.2
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
143
0.77
0.32
1.1
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
13
101
1.29
0.31
2.2
2.1
umol/l
55.0
55.8
—
7
75
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
312
2997
1.05
0.31
4.9
4.6
%
32.1
32.6
0.36
261
1975
(3003888) Timothy IgE Ab [Units/volume] in Serum
31
268
1.16
0.30
1.0
1.0
u/ml
1.5
3.2
1.21
15
133
(3032773) Endomysium IgG Ab [Titer] in Serum
20
166
1.21
0.29
1.2
1.0
titre
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
57
1.23
0.29
1.1
1.5
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
9
116
0.78
0.27
1.0
1.3
mmol/l
6.3
6.2
—
9
110
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
56
613
0.91
0.25
1.8
1.8
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
76
1.18
0.24
1.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
38
1.32
0.23
1.8
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
95
0.74
0.22
1.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
42
1.19
0.21
1.2
1.1
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
2.5
—
0
11
(3011841) English Walnut IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.0
—
0
6
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
0.5
—
0
6
(3017509) Phencyclidine [Presence] in Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
59
547
1.08
0.20
1.6
1.7
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
14
0.00
0.20
0.0
5.6
—
—
—
0
0
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
0.1
—
0
6
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
14
0.00
0.20
0.0
2.8
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
49
1.22
0.20
1.0
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
115
0.78
0.20
1.8
1.5
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
6
50
1.20
0.19
1.3
1.1
—
0.7
—
0
30
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
58
1.21
0.18
2.7
1.7
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
10
82
1.22
0.17
2.5
1.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
14
120
1.17
0.16
1.9
2.5
ml
2559.3
1860.5
1.02
14
105
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
70
1.14
0.16
1.0
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
30
273
1.10
0.16
1.3
1.3
mmol/l
10.3
7.5
2.07
19
198
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
71
1.13
0.16
1.0
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1839
18491
0.98
0.15
49.7
19.4
g/l
330.4
332.2
10.83
1826
18348
(3010144) Erythrocytes [#/volume] in Synovial fluid
25
226
1.11
0.15
1.3
1.4
e6/l
26924.1
59141.5
0.50
14
158
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
18
159
1.13
0.15
2.8
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
106
1102
0.96
0.13
1.5
1.6
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
146
1504
0.97
0.12
2.5
2.4
au/ml
59.1
22.8
—
5
73
(44813793)
12
134
0.90
0.08
1.1
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
71
0.84
0.07
1.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
76
1.05
0.07
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
10
112
0.89
0.07
1.2
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
122
0.90
0.07
1.2
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
133
1356
0.98
0.06
1.3
1.3
au/ml
28.3
60.3
—
5
57
(3006462) Nitrate [Presence] in Urine
9
104
0.86
0.06
1.7
3.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2317
23206
0.99
0.06
36.0
14.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
21
199
1.06
0.04
1.0
1.0
u/ml
1.6
2.6
0.27
11
73
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
32
308
1.04
0.04
1.1
1.1
u/ml
0.8
1.5
0.66
16
132
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2397
23945
1.01
0.04
29.2
10.6
u/l
36.9
25.9
29.35
2374
23045
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
11
118
0.93
0.02
1.1
1.1
—
11.9
—
0
34
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
140
1413
0.99
0.02
1.3
1.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
31
319
0.97
0.02
1.2
1.1
—
11.3
—
0
14
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
44
431
1.02
0.02
1.6
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
63
638
0.99
0.01
1.1
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
27
263
1.03
0.01
1.0
1.0
u/ml
0.4
1.3
—
10
119
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
60
607
0.99
0.01
1.6
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
22
214
1.03
0.00
1.4
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
18
181
0.99
0.00
1.1
1.1
u/ml
1.4
4.6
—
9
73
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
47
475
0.99
0.00
1.5
1.4
e6/l
14.3
31.4
0.56
34
365
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
47
475
0.99
0.00
1.6
1.4
e6/l
661.4
1499.2
0.58
40
389
(4211845)
11
114
0.96
0.00
2.5
3.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
24
244
0.98
0.00
1.0
1.0
u/ml
0.5
3.0
—
7
58
(3002523) Influenza virus A Ag [Presence] in Specimen
26
262
0.99
0.00
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
52
518
1.00
0.00
1.4
1.8
iu/l
9.4
4.8
0.61
13
164
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
569.7
—
0
5
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
7.8
—
0
5
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
36.4
—
0
5
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
8
0.00
0.00
0.0
1.7
—
1.4
—
0
8
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
2.0
—
4.7
—
0
7
(3003740) Influenza virus B Ag [Presence] in Specimen
26
260
1.00
0.00
1.1
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
63
0.95
0.00
1.3
1.6
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
9
0.00
0.00
0.0
1.1
—
7.6
—
0
9
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
95
0.95
0.00
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint K11_FIBROCHIRLIV and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_FIBROCHIRLIV | 4.932 [4.37, 5.57] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.028 |
During the follow-up period (1.1.1998 — 31.12.2019), 2888 out of 6837 females with K11_FIBROCHIRLIV died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_FIBROCHIRLIV | 7.217 [6.12, 8.51] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 3915 out of 6725 males with K11_FIBROCHIRLIV died.
Mortality risk
Mortality risk for people of age
years, who have K11_FIBROCHIRLIV.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.42% | 1.153% |
| 5 | 2.374% | 6.99% |
| 10 | 6.022% | 16.152% |
| 15 | 11.499% | 29.88% |
| 20 | 19.055% | 47.457% |
Relationships between endpoints
↥Index endpoint: K11_FIBROCHIRLIV – Fibrosis and cirrhosis of liver
GWS hits: 3
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data